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INTRODUCTION AND OUTlINE OF THE THESIS
1
General introduction
Acid-base abnormalities are common and clinically relevant in critically ill patients1,2. 
For example, severe metabolic acidosis has great impact on organ function and is 
clearly associated with adverse outcome3. Also metabolic alkalosis exerts adverse 
effects on cardiovascular, pulmonary and metabolic function4 and is associated 
with increased ICU mortality5. Although metabolic acid-base abnormalities are 
often related to the underlying disease, a significant proportion is iatrogenic6. A 
thorough understanding of acid base physiology and pathophysiology is essential 
to the critical care physician. Diagnosis of the cause of an acid-base derangement 
enables the clinician to identify markers of outcome and institute or avoid specific 
treatments. 
Systematic approaches for the diagnosis of acid base disorders
A systematic approach is essential in the diagnosis of acid-base disorders7. Several 
approaches to interpret acid-base derangements have been developed since the 
beginning of the past century8. Each approach differs only in the assessment of the 
metabolic component6. All approaches agree with respect to the respiratory 
component, represented by the PaCO2, an independent variable influencing pH. 
The influence of carbon dioxide on pH is clarified by the equilibrium reaction 
describing how carbon dioxide combines with water to form carbonic acid (H2CO3):
CO2 + H2O  H2CO3  H+ + HCO3– 
The traditional approach to acid-base disorders developed from the work of 
Henderson and Hasselbalch in 19169 is still the most widely used in clinical 
practice10. They introduced the well-known Henderson-Hasselbalch equation:
                               
  [HCO3–]
pH= 6.1 + log 
  0.03 x PaCO2   
The use of [HCO3-] to describe the metabolic component of an acid-base disturbance 
is easy to apply in common clinical problems. However, as can be noticed from the 
carbonic acid equilibrium reaction, changes in PaCO2 will inevitably cause a change 
in [HCO3-]. Therefore, other methods of assessing the metabolic component, by 
standardising to a normal PaCO2 value, have been developed after the original 
work of Henderson and Hasselbalch. The ‘base excess method’ of Siggaard- 
Andersen11, introduced in 1958, is now commonly used in blood gas analysers to 
overcome this issue. Base excess is defined as the change in strong acid or base 
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needed to restore pH of plasma in vitro to normal at normal PaCO2. To improve the 
accuracy of the base excess, the formula was adjusted in 1963, assuming a 
standard hemoglobin concentration of 5 g/l to compensate for bicarbonate’s large 
apparent volume of distribution12. This formula of standard base excess more 
accurately predicts the quantity of strong acid or base required to restore the pH of 
plasma in-vivo to normal at normal PaCO2.  Unfortunately, clinical interpretation of 
serial measurements of the (standard) base excess in a critically ill patient is difficult, 
for example when simultaneous large alterations in hemoglobin concentration and/or 
PaCO2 are present. In summary, traditional approaches provide a quantification of 
the metabolic component of an acid-base disorder. However, it is recognized that 
the traditional approaches of both Henderson Hasselbalch and Siggaard-Andersen 
are inadequate to fully understand the cause of a metabolic derangement10,13,14. 
Knowledge about the cause of the derangement is vital in the treatment of critically 
ill patients, as well as a thorough understanding of the compensatory mechanisms 
of the body. The ‘anion gap concept’ was developed to give more insight in the 
cause of a metabolic acidosis by demonstrating or excluding the presence of 
unmeasured anions:
Anion gap (AG) = [Na+] + [K+] – [Cl–] – [HCO3–]
Normal values of the AG vary (depending on the local laboratory) between 8 and 12 
mEq/l and represent the net charge of all unmeasured positively and negatively 
charged serum ions and proteins. In case of a metabolic acidosis, an increased AG 
indicates the presence of unmeasured anions. 
However, the usefulness of the AG is limited because of various confounding 
factors15. Its main drawback is that only four electrolytes are measured and 
incorporated in its calculation. Values of other charged components are assumed 
to be normal, but, especially in critically ill patients, this is frequently not the case. 
The most important example is albumin, which is the most abundant negatively 
charged serum protein. The majority of critically ill patients is hypoalbuminemic16. 
In these patients, the normal value of the AG decreases and this needs to be 
corrected for, either by adjusting the normal range or by correcting the calculated 
anion gap for albumin levels17. If this is not appreciated, it may lead to a false 
interpretation of the AG as being normal. 
Because of the limited value of the AG in the analysis of complex metabolic 
acid-base derangements, the quantitative physico-chemical approach first described 
by Stewart in 198118 and later modified by Figge et al19,20, has gained interest during 
the past decade, especially in the critical care literature10,14,21. 
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Peter Stewart died in 1993 and therefore has not been able to enjoy the popularity 
his original work has gained. The Stewart approach enables the clinician to identify 
and quantify all contributing metabolic and respiratory factors in an acid-base 
disorder. This thesis focuses on this physico-chemical approach and its application 
in critically ill patients with metabolic derangements. In this thesis, this approach 
will be referred to as the ‘Stewart approach’.
The Stewart approach
The Stewart approach relies on the fundamental principles of conservation of both 
mass and electroneutrality. Moreover, central to the understanding of this approach 
is the fact that the human body provides an extensive, essentially inexhaustible 
source of H+ ions because of its high water content, which is always partially 
dissociated in H+ and OH- 10,14,18. According to this approach, only 3 independent 
variables can change the extent of dissociation of water, and thereby [H+] and thus 
blood pH: the strong ion difference (SID), the total amount of weak acids (mainly 
phosphate and albumin), and PaCO2. Based on the principles of electroneutrality 
and conservation of mass, the strong ion difference (SID) represents the net 
balance between strong (fully dissociated) cations and strong anions in plasma 
according to the following formula (all concentrations in mEq/l):
SID = [Na+]+ [K+]+ [Ca2+]+ [Mg2+]– ([Cl–]+ [lactate–])
Decreases in the strong ion difference (such as those occurring in hyperchloremia, 
hyperlactatemia or dilution) lead to an increase in the dissociation of water, to 
maintain electroneutrality, and thereby to a fall in the pH. The opposite happens if 
the strong ion difference increases. Normal values of SID in healthy human subjects 
are 38-42 mEq/l6,22-25. 
Obviously, the human body cannot be charged positively or negatively. The formula 
of SID does not take into account the negative charge of weak acids and other 
weak anions present in blood. Therefore, this is named the ‘apparent strong ion 
difference’ (SIDapp).  Calculation of the anionic effects of albumin was made 
possible by the work of Figge et al.19,20 The sum of the charges of the weak acids 
(serum albumin and phosphate) and bicarbonate, representing the effective strong 
ion difference (SIDeff) is described in the following equation: 
SIDeff = (2.46 x 10-8 x PaCO2 (mm Hg)/10-pH) + ([albumin in g/l] x 0.123 x (pH – 0.631)) 
+ ([phosphate in mmol/l] x (0.309 x pH – 0.469))
14
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Normally, values of SIDapp and SIDeff are nearly equal (according to the law of electro-
neutrality), as no significant amounts of unmeasured anions, other than lactate, are 
present in the blood during physiological circumstances in the absence of disease. 
However, in critically ill patients, unmeasured ions are likely to increase due to for 
example impaired clearance secondary to renal or hepatic failure. Unmeasured 
anions represent the “gap” between apparent and effective strong ion difference. 
When present, they are responsible for dissociation of water and a fall in pH. This 
gap is called the ‘strong ion gap’ (SIG) and is calculated by the following formula:
SIG = SIDapp – SIDeff
The positively and negatively charged components of SIDapp and SIDeff in human 
plasma are illustrated in figure 1.
In critically ill patients, an increased SIG, indicating an increased amount of strong 
unmeasured anions other than lactate, is present in for example renal failure (uremic 
toxins)26, hepatic failure27, ketoacidosis, intoxications and sepsis28. like lactate, it 
might be a marker of tissue hypoperfusion and/or tissue damage in for example 
post cardiac arrest patients as well29,30. However, assessment of the SIG at the 
bedside is complex, mainly due to the complicated calculation of SIDeff.
Figure 1   Schematic representation of the cationic (left) and anionic (left) 
contributors to the different Stewart parameters. For reasons of clarity,  
the relative quantities of the components do not completely represent 
actual values.
Na+
K+
lactate–
HCO3–
SIDapp SIDeff
SIG
PO4–
Alb–
Ca2+
Mg2+
Cl–
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Interpretation of metabolic acid base derangements according to 
the Stewart approach
According to the physicochemical theory, metabolic acidosis can only be the result 
of decreases in SIDapp (mainly due to hyperchloremia, hyperlactatemia and dilution13), 
increases in the SIG (unmeasured anions), or increases in the concentration of 
weak acids (hyperalbuminemia, which is described31 but extremely rare, and hy-
perphosphatemia). likewise, metabolic alkalosis can only be the result of increases 
in the SIDapp (mainly due to hypochloremia and contraction of plasma volume) or 
decreases in the concentrations of the main weak acids. Primary hypoproteinaemic 
alkalosis is described in critically ill patients32. However, critically ill patients with 
hypoalbuminemia often have a normal pH due to concurrent reduced SIDapp33. 
Critically ill patients often have complex acid base abnormalities with co-existence 
of the above-mentioned abnormalities. Therefore, the Stewart approach may be of 
additional value compared to the more conventional approaches. For example, 
using the Stewart approach, the cause of metabolic acidosis in critically ill patients 
with acute renal failure has been identified and quantified: it is a result of the balance 
between the acidifying effect of increased SIG and hyperphosphatemia and the 
smaller alkalinizing effect of hypoalbuminemia34. The Stewart approach not only 
enables us to identify these contributing factors, but also makes it clear to what 
extent each factor influences pH.
Regulation of pH according to the Stewart approach
By understanding that only PaCO2, strong ion difference and the total concentration 
of weak acids can independently influence pH, the Stewart approach also gives 
insight in the way the human body can regulate it. No physiological mechanism is 
known to control concentrations of weak acids for acid-base purposes10 and 
concentrations of the weak acids are primarily dependent of other mechanisms 
(like calcium homeostasis in case of phosphate). So, apart from adjusting PaCO2 
by alveolar ventilation, the only possible mechanism to correct pH in case of an 
acid-base disturbance is by regulation of the SIDapp. Plasma [Na+] is mainly 
controlled for the purpose of maintaining intravascular volume and osmolality and 
[K+] is tightly regulated to ensure appropriate cardiac and neuromuscular function10. 
Therefore, by adjusting urinary excretion of chloride (accompanied by NH4+), 
without the simultaneous excretion of a strong cation, this is most likely how the 
kidneys can regulate plasma SIDapp and pH13,14.
In summary, the Stewart approach provides a robust strategy for studying acid-base 
disorders and can provide important insights into metabolic derangements. 
However, due to its complexity, its implementation at the bedside is cumbersome 
and this has limited its clinical applicability.
16
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Aims and outline of this thesis
The aim of this thesis was to perform clinical studies using the Stewart approach to 
explore acid base disorders in critically ill patients, with a distinct focus on metabolic 
derangements and the role of renal function.
In the first part of this thesis, several aspects of the etiology of metabolic acidosis 
in the ICU are discussed. In chapter 2, the nature of metabolic acidosis in ICU 
patients is explored. The traditional approach is compared with the Stewart 
approach with respect to diagnostic performance and applicability at the bedside. 
In chapter 3, we searched for the nature of strong unmeasured anions, which 
represent a frequent, but unidentified, cause of metabolic acidosis in the ICU with 
prognostic implications. In chapter 4, the role of renal dysfunction in the etiology of 
metabolic acidosis is examined. 
In the second part of this thesis, the Stewart approach of metabolic alkalosis in the 
ICU is discussed. In chapter 5, a quantitative analysis of the effects of a therapeutic 
intervention in metabolic alkalosis, administration of acetazolamide, in the ICU is 
presented. Effects on urinary excretion as well as serum acid base variables are 
discussed.
In the third part of the thesis, several aspects of ICU patients with an apparent 
normal acid base state are described. In chapter 6, we described Stewart 
parameters in critically ill patients with apparent normal acid base state according 
to the traditional approach. We investigated whether a normal pH, BE and PaCO2 
represent a truly normal acid base state or a mixed metabolic acid base disorder in 
these patients. Furthermore, we explored the kinetics of acid-base parameters of 
ICU patients who develop a normal pH during the first week of admission. Finally, 
several contributing factors to mixed acid base disorders according to Stewart were 
identified. 
Finally this thesis is concluded with a summary and a general discussion of the 
findings in chapter 7.
17
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Part I
Stewart approach of 
metabolic acidosis in the ICU   
Part I
Chapter 2
Conventional or 
physicochemical approach 
in intensive care unit patients 
with metabolic acidosis
Miriam Moviat, Frank van Haren, Hans van der Hoeven
Critical Care 2003; 7:R41-R45
Chapter 2
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CHAPTER 2
Summary
Introduction Metabolic acidosis is the most frequent acid–base disorder in the 
intensive care unit. The optimal analysis of the underlying mechanisms is unknown.
Aim To compare the conventional approach with the physicochemical approach in 
quantifying complicated metabolic acidosis in patients in the intensive care unit.
Patients and methods We included 50 consecutive patients with a metabolic 
acidosis (standard base excess ≤–5). We measured sodium, potassium, calcium, 
magnesium, chloride, lactate, creatinine, urea, phosphate, albumin, pH, and arterial 
carbon dioxide and oxygen tensions in every patient. We then calculated HCO3–, 
the base excess, the anion gap, the albumin-corrected anion gap, the apparent 
strong ion difference, the effective strong ion difference and the strong ion gap.
Results Most patients had multiple underlying mechanisms explaining the 
metabolic acidosis. Unmeasured strong anions were present in 98%, hyperchloremia 
was present in 80% and elevated lactate levels were present in 62% of patients. 
Calculation of the anion gap was not useful for the detection of hyperlactatemia. 
There was an excellent relation between the strong ion gap and the albumin- 
corrected and lactate-corrected anion gap (r2=0.934), with a bias of 1.86 and a 
precision of 0.96.
Conclusion Multiple underlying mechanisms are present in most intensive care 
unit patients with a metabolic acidosis. These mechanisms are reliably determined 
by measuring the lactate-corrected and albumin-corrected anion gap. Calculation 
of the more time-consuming strong ion gap according to Stewart is therefore 
unnecessary.
25
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Introduction
Metabolic acidosis is one of the most frequent acid–base disorders occurring in 
the intensive care unit (ICU)1. It may contribute to the morbidity and mortality 
associated with shock, although it may also have some protective effects. Traditional 
approaches are often inadequate to explain the complexity of acid–base 
derangements in critically ill patients. The physicochemical approach described by 
Stewart is based on two major principles: electroneutrality and conservation of 
mass2,3. According to this theory, there are three variables that independently 
determine the hydrogen ion concentration. These variables are the strong ion 
difference, the total concentration of nonvolatile weak acid (primarily serum proteins 
and phosphate), and the carbon dioxide tension (PCO2)4,5. Although the Stewart 
approach may give a better understanding of the mechanisms that underlie an 
acid–base disorder, it is more time consuming than conventional methods and is 
therefore less convenient in daily practice6. The purpose of the present study was 
to compare two different methods of quantifying metabolic acidosis in patients 
admitted to an ICU. We were especially interested in whether acid–base analysis 
according to the physicochemical approach could result in important changes in 
diagnosis, and therefore in therapy. We hypothesised that a less time-consuming 
method such as the lactate-corrected and albumin-corrected anion gap would be 
as efficient as the calculations according to the physicochemical approach in 
identifying the major causes of metabolic acidosis: hyperchloremia, hyperlactate-
mia and the presence of other unmeasured strong anions.
Methods
The study was conducted in a single, mixed medical and surgical ICU of the Jeroen 
Bosch Hospital, ‘s-Hertogenbosch, The Netherlands from August 2001 until 
February 2002. The local medical ethical committee waived informed consent.
We studied 50 consecutive patients who were either admitted with a metabolic 
acidosis or who developed a metabolic acidosis during their stay in the ICU. 
Metabolic acidosis was defined as a standard base excess (SBE) ≤ –5. In all 
patients we measured pH, arterial oxygen tension, arterial carbon dioxide tension 
(PaCO2), sodium, potassium, chloride, magnesium, calcium, lactate, creatinine, 
urea, phosphate and albumin in a single arterial blood sample. Bicarbonate was 
calculated using the Henderson–Hasselbach equation (pH=6.1+log ([HCO3–
]/0.0301 PaCO2) and the SBE using the Siggaard–Andersen formulae. The urine 
was screened for the presence of ketones in every patient. The anion gap (AG) was 
26
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calculated with the formula AG=[Na+]+[K+]–[Cl–]–[HCO3–]. The anion gap 
corrected for albumin and lactate (AGcorr) was calculated with the formula 
AGcorr=AG+0.25x(40–[albumin])–lactate7. The apparent strong ion difference 
(SIDapp) was calculated using the formula SIDapp=[Na+]+[K+]+[Ca2+]+[Mg2+]–
[Cl–]–[lactate–]. The effective strong ion difference (SIDeff) was calculated using the 
formula SIDeff=(2.46 x 10-8 x PaCO2 (mm Hg)/10-pH) + ([albumin in g/l] x 0.123 x 
(pH – 0.631)) + ([phosphate in mmol/l] x (0.309 x pH – 0.469)).  The strong ion gap 
(SIG) was calculated by subtracting the effective strong ion difference from the 
apparent strong ion difference: SIG=SIDapp–SIDeff.
The serum reference range for a normal AG in our laboratory is 4–12 mmol/l (Aeroset 
2002; Abbott, Hoofddorp, the Netherlands). AG>12mmol/l was considered 
elevated. SIG>0 points to the presence of unmeasured strong anions and was 
considered abnormal8. Fluid resuscitation was performed with isotonic 0.9% NaCl 
or short acting starch products (chloride concentration 154 mmol/l). Polygeline 
colloidal fluids were not used because they not only increase serum chloride levels, 
but probably also increase the SIG9.
Acute Physiology and Chronic Health Evaluation II data were collected for each 
patient for the first 24 hours after admission. A decrease in renal function was 
defined as a creatinine concentration > 110 μmol/l for males and > 100 μmol/l for 
females. All patients were followed up to determine the 28-day survival.
Results are reported as the mean±standard deviation or the median (25th percentile, 
75th percentile) depending on the distribution of the data. We performed linear 
regression analysis to compare the SIG with the AGcorr. We calculated the bias (the 
mean difference between the two methods) after subtracting 12 from the AGcorr and 
the precision (the standard deviation of the bias). The limits of agreement were 
defined by ±2 standard deviations10.
Results
Fifty patients were enrolled in the study. Patient characteristics are presented in 
Table 1, and acid–base and electrolyte data for the study population are presented 
in Table 2. 
Twenty-nine patients had evidence of a decreased renal function.
27
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Urine samples were positive for ketones in six patients. Hyperchloremia (serum 
chloride ≥110mmol/l) was present in 40 patients (80%), and hyperlactatemia (serum 
lactate ≥2mmol/l) was present in 31 patients (62%). The contributions of the three 
main causes of metabolic acidosis (hyperchloremia, hyperlactatemia and increased 
Table 1   Patient characteristics
Age (years) 65 (26-89)
Sex (male/female) 26/24
Acute Physiology and Chronic Health Evaluation II 22 (9-43)
Mechanical ventilation (%) 92
Standardised mortality ratio 0.90
Hospital mortality (%) 38
Diagnosis
Septic shock 22
Hypovolemic shock 15
Cardiogenic shock 9
Other 4
Data presented as median (interquartile range)
Table 2   Acid-base and electrolyte data
pH 7.30 (7.21, 7.33)
Arterial carbon dioxide tension (mmHg) 37 (29, 42)
Standard base excess -9 (-11, -7)
Sodium (mmol/l) 138 (135, 141)
Potassium (mmol/l) 4 (3.5, 4.4)
Chloride (mmol/l) 114 (110, 117)
lactate (mmol/l) 2.3 (1.4, 3.0)
Albumin (g/l) 16 (13, 19)
Strong ion gap (mEq/l) 3.6 (2.0, 6.0)
Data presented as median (interquartile range)
28
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levels of other unmeasured strong anions) are presented in Table 3. Of the 29 patients 
with renal failure, 14 had elevated lactate levels, 20 had hyperchloremia and all 29 
had an elevated SIG. Calculation of the uncorrected AG was not useful for the 
detection of hyperlactatemia: sensitivity 45%; specificity 16%; positive predictive 
value 47%; negative predictive value 15%. Calculation of the albumin AGcorr 
increased the sensitivity to 100%, but the specificity decreased to 11%. The positive 
and negative predictive values were 65% and 100%, respectively. The mean SIDapp 
was 27.8±4.3 mEq/l (normal 38–42mEq/l). In all but one patient the SIG was 
increased (median 3.61 mEq [1.99, 6.07]). There was a weak but significant 
correlation between the lactate levels and the SIG (r2=0.149, P=0.005). 
There was a very strong correlation between the AGcorr and the SIG (r2=0.934, 
P<0.001; Fig. 1). The bias was 1.86 and the precision was 0.96. The limits of agreement 
were therefore –0.06 and 3.78 (Fig. 2)
Table 3   Distribution of the three main underlying mechanisms of metabolic 
acidosis
Underlying mechanism Number of patients(%)
Increased strong ion gap 49 (98)
Increased lactate 31 (62)
Increased chloride 40 (80)
Increased strong ion gap + lactate 31 (62)
Increased strong ion gap + chloride 39 (78)
Increased lactate + chloride 25 (50)
Increased strong ion gap + lactate + chloride 25 (50)
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Discussion
The main finding of the present study was the excellent relationship between the 
AGcorr and the SIG in patients with a metabolic acidosis admitted to the ICU 
(r2=0.934). Furthermore, unmeasured strong anions excluding lactate were almost 
universally present in this unselected patient group, as was hyperchloremia.
Figure 1   Correlation between the albumin-corrected anion gap (AG) minus 
lactate and the strong ion gap(SIG).
Figure 2   Bland–Altman analysis of the albumin-corrected anion gap minus lactate 
(AGcorr) and the strong ion gap (SIG) (bias 1.81 and precision 0.96).
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A positive SIG indicating the presence of unmeasured strong anions was reliably 
detected by the AGcorr. Durward and colleagues studied 540 children, of whom 240 
developed a metabolic acidosis6. In their study, unmeasured strong anions were 
also the main component of tissue acids. In accordance with the present study, the 
AGcorr had the best discriminatory ability (area under curve 0.95) and the tightest 
determination coefficient for the detection of tissue acids (r2=0.86). Durward and 
colleagues also found a weak but significant inverse correlation between the total 
amount of tissue acids and the chloride: sodium ratio. A chloride:sodium ratio > 0.79 
was able to exclude a raised tissue acid level with a positive predictive value of 81% 
and a likelihood ratio of 4.5. The upper normal range for the chloride:sodium ratio 
in our hospital is 0.79. Thirty-eight (76%) patients had a chloride: sodium ratio > 0.79 
in our study. This is in agreement with our definition of hyperchloremia using an 
absolute level of 110 mmol/l (80% hyperchloremia). We also found a significant 
negative correlation between the amount of unmeasured strong anions and the 
chloride:sodium ratio (r2=0.54, P<0.001). The unmeasured strong anions involved 
in the SIG remain largely unidentified. These anions appear, for example, in the 
circulation during sepsis and liver failure, and may be a variety of organic and 
inorganic compounds8. The use of urea-linked polygelines, for example, as the 
priming fluid for the extracorporeal circuit during cardiac surgery has also been 
shown to increase the SIG9. They represent approximately 5.6 mEq anions per 500 
ml fluid. Also, the (over)use of several medications such as salicylates and penicillin 
can be a cause of a positive SIG. The importance of a raised SIG in clinical practice, 
however, is unknown. Cusack and colleagues recently showed that the pH and 
SBE were better outcome predictors than the SIG in a group of mixed medical and 
surgical ICU patients11. Furthermore, normal levels for the SIG in critically ill patients 
are unknown. We defined SIG>0 as abnormal but these data were based on 
measurements in healthy volunteers8. Cusack and colleagues found a much higher 
SIG in critically ill patients but they provide no separate data for the patients with a 
normal SBE. If we assume that normal AG ≤12mEq/l, the intercept in Figure 1 
suggests that the normal SIG in our critically ill patients is close to 2mEq/l.
A significant part of the acidosis in the present patients is probably related to the 
resuscitation with isotonic saline and starch products. This can be deduced from 
the frequent occurrence of hyperchloremia in our patients in relation to the plasma 
sodium concentration. Both have a chloride concentration of 154 mmol/l. This 
results in a reduction of the strong ion difference, which in turn produces an increase 
in the number of hydrogen ions to preserve electrical neutrality. The term ‘dilutional 
acidosis’ used in relation to high volume resuscitation should therefore be abandoned. 
Hyperchloremic acidosis after fluid resuscitation is a well-known phenomenon in 
the ICU12-14. The clinical consequences, however, are unknown.
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There is no proof to date that the use of a more balanced resuscitation fluid will 
result in a better patient outcome. Kellum showed that a balanced resuscitation 
fluid (Hextend®, Abbott, Chicago, Il, USA), chloride concentration 124mmol/l) 
resulted in a better short-term survival in a rat sepsis model compared with isotonic 
saline15. Waters and colleagues compared isotonic saline with lactated Ringer’s 
solution in patients undergoing abdominal aortic aneurysm repair16. Patients in the 
normal saline group developed a more severe acidosis and received a larger 
volume of platelet transfusion. However, there were no differences in the duration of 
mechanical ventilation, the ICU stay, the hospital stay and the incidence of 
complications. Furthermore, the use of Ringer’s lactate has been associated with 
postoperative hypercapnic acidosis and hyponatremia17. Therefore, the importance 
of resuscitation-induced hyperchloremic acidosis remains to be determined. Hyper-
lactatemia was the third cause of metabolic acidosis in the present study. Considering 
the high number of patients with sepsis, this is not surprising. The importance of 
hyperlactatemia as a marker of shock and its prognostic significance are well 
known. We demonstrated that a normal AG does not exclude the presence of 
hyper lactatemia (sensitivity 45%, negative predictive value 15%). Although the 
sensitivity of the AGcorr for the detection of hyperlactatemia increased to 100%, it 
was not specific (11%). Therefore, determination of the (corrected) AG is not a good 
substitute for the direct measurement of lactate in patients with a metabolic acidosis 
in the ICU. As expected, there was a weak but significant correlation between 
lactate levels and the SIG. This weak correlation was especially pronounced in 
patients with normal or slightly elevated lactate levels.
Several weaknesses of the present study should be mentioned. We only studied 
patients with a clear metabolic acidosis (SBE ≤ –5), and the SIG and lactate levels 
of patients with a normal or marginally normal SBE are therefore unknown. Furthermore, 
although the patients were included immediately when the SBE became ≤ –5, changes 
over time may have influence over the type of acidosis detected. 
Conclusion
The present study demonstrates that multiple underlying mechanisms are present 
in most ICU patients with a metabolic acidosis. These mechanisms are reliably 
determined by measuring the lactate-corrected and albumin-corrected anion gap. 
Calculation of the more time-consuming strong ion gap according to Stewart, 
although a gold standard, is therefore unnecessary for clinical purposes. Further 
studies should focus on the nature and importance of the unmeasured strong 
anions that are almost universally present in these patients.
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Summary
Objective The physicochemical approach, described by Stewart to investigate the 
acid-base balance, contains the strong ion gap (SIG), a quantitative measure of 
‘unmeasured’ anions, which strongly correlates to the corrected anion gap. The 
chemical nature of these anions is for the most part unknown. We hypothesised 
that amino acids, uric acid and organic acids could contribute to the SIG. 
Design Prospective observational study.
Setting Intensive Care Department of an academic hospital.
Patients Consecutive ICU patients (n=31) with metabolic acidosis, defined as a pH 
<7.35 and a base excess ≤-5 mmol/l.
Interventions A single arterial blood sample was collected.
Measurements The SIG was calculated and two groups were compared: patients 
with SIG ≤2 mEq/l and patients with SIG ≥5 mEq/l. ‘Unmeasured’ anions were 
examined by ion-exchange column chromatography, reverse-phase high performance 
liquid chromatography (HPlC) and gas chromatography/mass spectrometry (GC-MS) 
measuring amino acids, uric acid and organic acids respectively.
Main Results Comparison of patient characteristics of both SIG groups showed 
that age, gender, APACHE II, pH, base excess and lactate were not statistically 
significantly different. Renal insufficiency, sepsis and mortality were more prominent 
in the SIG ≥5 mEq/l group (n=12, median SIG=8.3 mEq/l). Concentrations of 
the anionic compounds aspartic acid, uric acid, succinic acid, pyroglutamic acid, 
p-hydroxyphenyllactic acid and the semi-quantified organic acid homovanillic acid 
were all statistically significantly elevated in the SIG ≥5 mEq/l group compared to 
the SIG ≤2 mEq/l group (n=8, median SIG=0.6 mEq/l). Overall, the averaged 
difference between both SIG groups in total anionic amino acids, uric acid and 
organic acids concentrations contributed to the SIG for respectively 0.07% (5 μEq/l, 
P=NS), 2.2% (169 μEq/l, P=0.021) and 5.6% (430 μEq/l, P=0.025).
Conclusions Amino acids, uric acid and organic acids together accounted for only 
7.9% of the SIG in ICU patients with metabolic acidosis.
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Introduction
Metabolic acidosis is the most frequently observed acid-base disorder occurring in 
the intensive care unit (ICU)1. The physicochemical approach described by Stewart 
provides a precise way of quantifying metabolic acidosis and gives insight into the 
main underlying mechanisms2,3. This approach states that changes in blood pH are 
regulated by three independent variables: partial pressure of carbon dioxide (PaCO2), 
strong ion difference and total weak acid concentrations4,5. PaCO2 determines the 
pH by chemical equilibrium and is dependent on alveolar ventilation and metabolic 
CO2 production. The apparent strong ion difference (SIDapp) is the difference between 
the sum of all measured strong cations and strong anions. The effective strong ion 
difference (SIDeff) represents the effect of the weak acids albumin and inorganic 
phosphate on the balance of electrical charges in plasma. The difference between 
the calculated SIDapp and SIDeff constitutes the strong ion gap (SIG). Obviously, this 
calculated SIG is only an estimation of the real strong ion gap as only the most 
abundant ions are measured and used for its calculation.  In healthy humans the SIG 
equals zero. In critically ill patients a high SIG, defined as >2 mEq/l6, indicates the 
accumulation of ‘unmeasured’ anions in blood as a cause of  acidosis. There is a 
strong correlation between the SIG and the albumin and lactate corrected anion 
gap7. lactic acidosis has clearly been associated with increased mortality in critically 
ill patients8 and recent studies suggest that the presence of a high SIG is associated 
with adverse outcome as well9,10. Many studies have highlighted the presence of 
‘unmeasured’ anions in critically ill patients, but only few have attempted to address 
their chemical nature. Rarely, high concentrations of pyroglutamic acid cause SIG 
acidosis11,12. ‘Balanced’ fluids used during cardiopulmonary bypass13 and colloids 
containing gelatin are known to elevate the SIG14. Recently, intermediates of the 
tricarboxylic acid cycle (TCA cycle) have been proposed to contribute to the 
generation of a high SIG and (corrected) anion gap15. 
Considering the diversity of diseases associated with an increased SIG  or (corrected) 
anion gap like sepsis16, hepatic dysfunction2,11,12, (cardiogenic) shock17 and renal 
failure3, the nature of the ‘unmeasured’ anions is likely to cover a broad spectrum. 
We hypothesized that organic acids, amino acids and uric acid might explain a 
significant part of the SIG, because most of these compounds are negatively 
charged at physiological pH. Insight into the nature of the SIG may help clinicians 
to clarify the cause of metabolic acidosis in their severely ill patients. The present 
explorative study intended to estimate the contributions of amino acids, uric acid 
and organic acids to the increased SIG in critically ill patients with a metabolic 
acidosis. Considering the strong correlation between SIG and the more traditional 
(albumin and lactate corrected) anion gap, the results of this study apply to both.
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Materials and methods
Patients
This study was conducted in the mixed medical and surgical intensive care unit of 
the Radboud University Nijmegen Medical Centre, The Netherlands. The local 
medical ethical committee allowed the study and waived the need for informed 
consent, since there was no interference with routine clinical care.
We studied 31 consecutive adult patients who were either admitted with a metabolic 
acidosis or who developed a metabolic acidosis during their stay in the ICU. 
Metabolic acidosis was defined as a pH < 7.35 and a standard base excess (SBE) 
≤ -5 mmol/l. All patients had an arterial line in situ. Acute Physiology and Chronic 
Health Evaluation (APACHE) II data were collected for each patient for the first 24 
hours after admission. Data of fluid intake and output and relevant medication were 
retrieved from patient charts. ‘Hyperchloremic’ acidosis is defined as a ratio of the 
plasma chloride to plasma sodium concentrations exceeding laboratory reference 
ranges > 0.7918. lactic acidosis is defined as a lactate concentration >2.2 mmol/l. 
Acute renal failure (ARF) is defined as creatinine levels > 150 μmol/l and/or a 
1.5-fold rise as compared to baseline values. All patients were followed up to 
determine their survival in the ICU.
Measurements
In each patient pH, partial pressures of oxygen and carbon dioxide (PaO2 and 
PaCO2) and concentrations of sodium, potassium, chloride, magnesium, calcium, 
lactate, creatinine, urea, phosphate and albumin were measured in a single arterial 
blood sample. Simultaneously, an arterial blood sample was collected in a 3 ml 
lithium heparin tube for analysis of ‘unmeasured’ anions. This sample was cooled 
on ice immediately, centrifuged at 4°C and 1500 g for 10 minutes and stored at 
-80°C until analysis.
Calculations
The bicarbonate concentration was calculated using the Henderson-Hasselbalch 
equation (pH = 6.1 + log ([HCO3-]/0.0301 PaCO2) and the SBE using the Siggaard- 
Andersen formulae. The apparent strong ion difference (SIDapp) was calculated 
using the formula SIDapp = [Na+] + [K+] + [Ca2+] + [Mg2+] - [Cl-] - [lactate-]. The 
effective strong ion difference (SIDeff) was calculated using the formula SIDeff = 
(2.46 x 10-8 x PaCO2 /10-pH) + ([albumin] x 0.123 x (pH – 0.631)) + ([phosphate] x 
(0.309 x pH – 0.469)). The SIG was calculated by subtracting the effective strong ion 
difference from the apparent strong ion difference: SIG = SIDapp – SIDeff3. All 
above-mentioned concentrations are expressed in milliequivalents per liter, except 
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for the concentrations of albumin (g/l) and phosphate (mmol/l), whereas PaCO2 is 
expressed in mmHg.
To determine the influence of ‘unmeasured’ anions to the increased SIG, patients 
were prospectively divided into 3 groups based on their SIG value (see Figure 1): 
SIG ≤ 2.0 mEq/l (the ‘low or normal SIG group’), 2.0 mEq/l < SIG < 5.0 mEq/l (the 
‘intermediate SIG group’) and SIG ≥ 5.0 mEq/l (the ‘high SIG group’). With these 
SIG cut-off values we previously found that acidotic critically ill patients were 
approximately equally divided over the three SIG groups7. Subsequently, amino 
acids, uric acid and organic acids were measured (semi-)quantitatively in the low 
and high SIG groups. The relative contribution of the concentration of a measured 
anion to the SIG was calculated by dividing the ∆ mean measured anion concentration 
by the ∆ mean SIG concentration (∆SIG). In this calculation, ∆ represents the 
difference between the high and low (or normal) SIG groups.
Amino acid and uric acid analysis
Amino acid determination was based on ion-exchange column chromatography, 
which was performed on an AminoTac JlC-500/V amino acid analyzer (JEOl ltd., 
Tokyo, Japan), using lithium buffers and ninhydrin reagent. Plasma samples of 100 
μl were applied in a standard procedure with aminoethylcystine as internal standard 
and commercial mixtures of amino acids for quantification. Uric acid concentrations 
were measured on a reverse-phase high-performance liquid chromatography 
(HPlC) system, applying detection by photodiode array absorbance. Hereby, 
WatersTM Alliance 2695 Separations Module and WatersTM 996 Photodiode Array 
Detector (Waters Corporation, Milford, MA, USA) were employed. Two buffers were 
Figure 1   Unmeasured anions during metabolic acidosis.
pH<7.35 and BE ≤ –5
n=31 
SIG ≥ 5
“high”
n=12
SIG ≤ 2
“low”
n=8
2<SIG<5
“intermediate”
n=11
Sepsis +
n=6
Sepsis –
n=6
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used: buffer 1: 75% 0.05 mol/l KH2PO4, 25% methanol and buffer 2: 98% 0.025 
mol/l KH2PO4, 2% buffer 1. Sample volume was 50 μl plasma.
Organic acid analysis
Organic acids were quantified by comparing the obtained signal with a calibration 
curve of the pure compound. Some organic acids, for which no calibration curve 
had been obtained to allow quantification, were determined semi-quantitatively 
using the area under the curve. Organic acids were quantified by gas chromatography 
with flame-ionization detection (FID) on a HP 6890 Gas Chromatograph (Agilent, 
Amstelveen, The Netherlands) and a 8000 Top Gas Chromatograph and Trace 
Mass Spectrometer Plus (InterSciences Inc., Breda, The Netherlands) were used to 
verify the identity of all organic acids reported. The columns CP-Sil 8 CB and CP-Sil 
19 CB (Varian Inc., Middelburg, The Netherlands) were utilized. For the analysis, 
750 μl plasma was pre-treated by adding 100 μl internal standard (=3.8 mmol/l 
4-phenylbutyric acid), 100 μl 15 mg/ml ascorbic acid and a few droplets of 10% 
HCl to set the pH between 1 and 2. This mixture was adjusted to a volume of 3 ml 
with SETH buffer (0.25 mol/l sucrose, 2 mmol/l EDTA, 10 mmol/l Tris and 5x104 
units heparin/l) and saturated with approximately 0.5 gram NaCl. Subsequently, 
this mixture was extracted twice with 12.5 ml ethylacetate each time, after which 
both ethylacetate fractions were combined for further work-up. The samples were 
dried and N,O-bis (trimethylsilyl) trifluroacetamide (BSTFA) plus 1% trimethylchlo-
rosilane (TMCS) (Pierce, Etten-leur, The Netherlands) and chloroform 1:1 were 
added for derivatisation (1 hr at 60°C). Samples were loaded onto the GC and 
GC-MS machines.
1H-NMR spectroscopy
Plasma samples of 4 patients were subjected to 1H-nuclear magnetic resonance 
(proton NMR) spectroscopy as decribed before19 to analyse compounds not 
identified in the amino acid analysis. Additionally, 1H-NMR spectroscopy was used 
to quantify intermediates of the TCA cycle in these samples. The volume of the 
ultrafiltrate was 200 or 300 μl.
Statistics
Concentrations of the investigated acidic compounds were compared between the 
high and low SIG groups. In all cases the Mann-Whitney U test was applied for 
statistical significance (accepted at P<0.05), since the group sizes were relatively 
small. For nominal data the chi-square test was applied. Since this was an 
explorative study, we did not correct for multiple testing. The median (Md) and 
interquartile range (IQR: 25th percentile–75th percentile) were used to summarize 
the data.
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Results
Thirty-one patients were included in the study. Baseline clinical and acid-base-re-
lated characteristics of the low and high SIG groups are shown in Table 1. Data of 
the intermediate SIG group (2.0 mEq/l < SIG < 5.0 mEq/l, n=11) are not shown. 
Both groups were comparable with respect to age, gender, APACHE II, blood pH 
and SBE. In the high SIG group incidence of sepsis and renal insufficiency was 
significantly higher and there was a trend towards higher mortality (P=0.068).
Table 1   Baseline clinical and acid-base-related characteristics of ICU patients 
with metabolic acidosis divided according to their SIG
SIG ≤2.0 μEq/l
(n=8)
SIG ≥5.0 μEq/l 
(n=12)
P value
SIG, mEq/l 0.9 (0.04–1.59) 7.3 (5.62–9.61) <0.001a
Age, years 64.9 (31.9–75.5) 68.4 (57.5–74.6) 0.671
Male gender, n (%) 6 (75) 7 (58) 0.444
APACHE II 19 (16–25) 23 (20–29) 0.131
Mortality, n (%) 0 (0) 4 (33) 0.068
Predicted death rate 0.31 (0.22–0.52) 0.46 (0.34–0.68) 0.131
ARF, n (%) 0 (0) 9 (75) 0.006a
Sepsis, n (%) 0 (0) 6 (50) 0.017a
pH 7.31 (7.26–7.35) 7.29 (7.22–7.33) 0.353
SBE, mmol/l -6.1 (-7.5– -5.5) -9.0 (-10.0– -5.8) 0.105
PaCO2, mm Hg 39 (36–46) 39 (32–43) 0.485
SIDapp, mEq/l 27.1 (25.1–29.1) 33.1 (30.6–35.6) 0.002a
lactate, mmol/l 1.9 (1.3–2.5) 1.5 (1.0–2.5) 0.263
Albumin, g/l 18 (15–20) 15 (11–22) 0.416
Phosphate, mmol/l 1.04 (0.99–1.17) 1.79 (1.43–2.26) 0.009a
Plasma creatinine, μmol/l 84 (73–93) 217 (109–307) 0.006a
‘Hyperchloremia’, n (%) 8 (100) 11 (92) 0.402
Hyperlactatemia, n (%) 2 (25) 3 (25) 1.000
APACHE, Acute Physiology and Chronic Health Evaluation; ARF, acute renal failure; SBE, standard 
base excess; SIDapp, apparent strong ion difference. Data provided as median (interquartile range) 
unless otherwise noted. aStatistically significant.
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Amino acid analysis
Table 2 shows the plasma amino acids concentrations in the high and low SIG 
groups expressed in μmol/l. The total amino acids concentration is defined as the 
sum of single amino acid concentrations per patient. Aspartic acid, isoleucine and 
ornithine showed statistically significantly higher concentrations in the high SIG 
group compared to the low SIG group. The tryptophan concentration was 
significantly lower in the high SIG group. At physiological pH aspartic acid and 
glutamic acid are monovalent anions. The other amino acids have either no or a 
positive charge in blood (http://research.chem.psu.edu/brpgroup/pKa). Aspartic 
acid and glutamic acid together contributed 0.07% to the ∆SIG (7.7 mEq/l), as 
listed in Table 4.
Organic acid analysis
Table 3 shows plasma concentrations of the most important organic acids 
(expressed in μmol/l) in the high and low SIG groups. The total organic acids 
concentration is defined as the sum of the listed single organic acids concentrations 
per patient. Concentrations of succinic acid, pyroglutamic acid and p-hydroxyphe-
nyllactic acid were significantly elevated in the high SIG group compared to the low 
SIG group, but contributed each less than 0.2% to the ∆SIG. Total organic acids 
concentrations were significantly elevated in the high SIG group compared to the 
low SIG group and contributed 5.6% to the ∆SIG (see Table 4). In one patient, who 
was in a prolonged fasted state at ICU admission, a 3-hydroxybutyric acid 
concentration of 3.9 mmol/l was observed, which corresponded to 25% (3.9 
mEq/l) of the SIG of this patient (15.9 mEq/l). No other organic acids concentrations 
of this magnitude were observed.
Semi-quantitative analysis of organic acids
Among the semi-quantified organic acids homovanillic acid (P=0.022) was 
significantly elevated in the high SIG group compared to the low SIG group, whereas 
palmitic acid (P=0.025) and stearic acid (P=0.037) were significantly lower. There 
were no differences in the areas under the curve of several other components of the 
organic acid spectrum between both groups, for instance in patients to whom 
acetaminophen was administered (every patient in the low SIG group and to 6 out 
of 12 patients in the high SIG group).
Uric acid analysis
Concentrations of monovalent uric acid (see Table 3) were significantly elevated in 
the high SIG group compared to the low SIG group and contributed 2.2% to the 
∆SIG (see Table 4).
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Table 2   Plasma amino acids concentrations (μmol/l) in ICU patients with 
metabolic acidosis divided according to their strong ion gap (SIG)
Amino acids SIG ≤2.0 μEq/l 
(n=8)
SIG ≥5.0 μEq/l 
(n=12)
Median  
(interquartile range)
Median  
(interquartile range)
P value
Taurine 36 (19-54) 36 (23-52) 0.817
Aspartic acid* 4 (3-4) 9 (5-12) 0.001c
Hydroxyproline 6 (3-9) 6 (4-14) 0.216
Threonine 85 (65-100) 80 (54-96) 0.817
Serine 52 (43-74) 48 (43-68) 0.643
Asparagine 41 (38-45) 45 (31-60) 0.817
Glutamic acid* 36 (23-49) 27 (17-60) 0.396
Glutamine 474 (429-614) 569 (446-637) 0.396
Proline 100 (74-151) 129 (95-218) 0.165
Glycine 135 (128-148) 176 (122-237) 0.190
Alanine 290 (236-328) 244 (153-307) 0.190
Citrulline** 17 (14-33) 23 (20-45) 0.097
Valine 165 (136-177) 183 (151-223) 0.190
Cystine 43 (32-57) 50 (35-105) 0.247
Methionine 15 (13-19) 17 (15-29) 0.334
Isoleucine 33 (27-40) 45 (38-61) 0.023c
leucine 84 (70-91) 87 (81-123) 0.247
Tyrosine 54 (43-68) 57 (45-68) 0.758
Phenylalanine 63 (53-70) 84 (52-103) 0.190
Ornithine** 24 (18-44) 59 (44-82) 0.003c
Histidine 73 (57-93) 64 (57-76) 0.440
lysine** 140 (128-161) 128 (114-168) 0.355
3-Methylhistidine 11 (5-20) 22 (12-28) 0.064
Tryptophan 22 (17-26) 13 (10-15) 0.002c
Arginine** 51 (38-71) 48 (40-68) 0.908
Total amino acids 1977 (1907-2616) 2336 (1828-2763) 0.537
Total anionic amino acids, 
μEq/l
39 (27-53) 35 (31-72) 0.643
The compounds are listed in the order of their elution time. Amino acid predominantly present in 
*monovalent anion form or in **monovalent cation form at pH 7.0-7.5. c statistically significant
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Table 3   Plasma organic acids and uric acid concentrations (μmol/l) in ICU 
patients with metabolic acidosis divided according to their SIG
Organic acids SIG ≤2.0 μEq/l 
(n=8)
SIG ≥5.0 μEq/l 
(n=12)
Median 
(interquartile range)
Median 
(interquartile range)
P value
Glycolic acid* 96 (89–119) 103 (79–128) 0.969
Oxalic acid** 27 (21–48) 40 (28–62) 0.153
3-hydroxy(iso)butyric acid* 28 (18-55) 40 (20-161) 0.316
Methylmalonic acid** 7 (5–8) 7 (3–8) 0.969
Succinic acid** 6 (4–8) 8 (6–9) 0.024c
Malic acid** 15 (13–19) 16 (13–22) 0.460
Adipic acid** 4 (1–4) 6 (3–7) 0.060
Pyroglutamic acid* 22 (18-25) 41 (31-54) 0.002c
p-Hydroxyphenyllactic acid* 3 (2–5) 6 (3–11) 0.032c
Total organic acids 227 (203-252) 294 (250-356) 0.023c
Total organic acids, μEq/l 287 (264-327) 381 (312-438) 0.025c
Uric acid* 281 (218-326) 383 (296-507) 0.021c
The organic acids are listed in the order of their elution time. Acid present in *monovalent anion form 
or in **bivalent anion form at pH 7.0-7.5. cStatistically significant
Table 4   Contributions of the anions quantified to the ∆SIG
Absolute ∆SIG  
contribution (μEq/l)
Relative ∆SIG  
contribution (%)
Total anionic amino acids 5 0.07
Uric acid 169 2.2
Total organic acids 430 5.6
Total quantified anions 604 7.9
∆SIG, difference between the mean SIGs in the high and low SIG groups (7.7 mEq/l)
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Unidentified compounds in the amino acid spectra
In the amino acid spectra we detected unidentified compounds with very short 
elution times (~2 minutes), i.e. compounds that are predominantly in the mobile 
phase during the chromatographic separation (see Figure 2 for the high and low 
SIG groups). The areas of these peaks were significantly different between the high 
and low SIG groups (P<0.001). Median and [interquartile range] in the high SIG 
group were 153 and [93–384] compared to 31 and [30–35] arbitrary units in the low 
SIG group, respectively. In the low SIG group the areas of the peaks appeared at a 
constant low magnitude (min–max, 28–48), whereas the areas of the peaks in the 
high SIG group showed large variation (min-max, 36–688). Most chromatograms 
showed multiple peaks, partially overlapping each other. For every peak the ratio of 
the heights was calculated by dividing the height of the peak obtained at wavelength 
570 nm by the height of the peak obtained at 440 nm. These ratios, useful in identification 
of an amino acid, were significantly different in the high SIG group compared to the 
Figure 2   First part of the amino acid chromatogram that shows unidentified peaks 
in all 12 patients in the high strong ion gap (SIG) group (A) and all eight 
patients in the low SIG group (B). Hydrogen-1 nuclear magnetic resonance 
spectroscopy was applied to plasma samples of patients 1–4.
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low SIG group (Md [IQR]): 1.9 [1.4–3.3] to 0.9 [0.7–1.0], respectively, with P=0.001, 
which suggests different ninhydrin-positive compounds in both groups. These 
ratios and elution times did not match with the parameters of any known amino acid 
or other known ninhydrin-positive compound. The quantitative contribution of the 
unidentified compounds to the ∆SIG could be estimated roughly by comparing 
their signal to the signal of amino acids reacting well or poorly with ninhydrin. For 
this aim glycine and sarcosine were used, respectively, to obtain a range of the 
∆SIG contribution of the unidentified compounds. Accordingly, the estimated 
contribution of these unidentified compounds to ∆SIG  ranged from 0 to 1.7% (132 
μEq/l) in case of monovalent anions.
1H-NMR spectroscopy
In an attempt to identify some of the unknown peaks plasma samples of 4 selected 
patients (assigned as ‘Patient 1’ to ‘Patient 4’, see Figure 2) were subjected to 
1H-NMR analysis. Selection of these patients was based on the shape and size of 
their unknown peaks in the amino acid chromatogram. Both ‘Patient 1’ and ‘Patient 2’ 
of the high SIG group (SIG: 10.0 and 6.8 mEq/l respectively) showed a large peak 
in the amino acid spectrum, each probably reflecting a single compound (area, 
ratio, retention time (RT): 688, 3.6, 2.06 min and 483, 3.0, 2.05 min, respectively). 
Figure 3 shows the 1H-NMR spectrum of ‘Patient 1’. In this spectrum resonances of 
multiple, overlapping compounds between 1.2 and 1.08 parts per million (ppm) 
were observed, but could not be identified. Interestingly, ‘Patient 2’ also showed 
resonances of multiple, overlapping compounds between 1.2 and 1.08 ppm. These 
resonances were absent in the 1H-NMR spectrum of the control ‘Patient 4’ of the 
low SIG group (SIG: 0.5 mEq/l), who showed a small peak in the amino acid 
spectrum (area, ratio, RT: 34, 1.1, 2.08 min). In ‘Patient 3’ a very broad peak was 
observed, the composition of it could not be determined in the NMR analysis. No 
additional known compounds with high concentrations could be detected by 
1H-NMR spectroscopy.
Various intermediates of the TCA cycle could be quantified. In all 4 plasma samples 
concentrations of trivalent citrate and isocitrate were less than 45 μEq/l, concentrations 
of bivalent alpha-ketoglutarate, fumarate and malate were less than 30 μEq/l and 
concentrations of bivalent succinate did not exceed 12 μEq/l.
Metabolites associated with the presence of sepsis
In order to explore the presence of ‘unmeasured’ anions specific for sepsis, 
concentrations of the investigated anionic compounds were compared between 
septic patients (n=6) and non-septic patients (n=6) in the high SIG group. Between 
these groups, serum creatinine concentrations were not statistically different (P=0.688). 
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Concentrations of p-hydroxyphenyllactic acid were significantly increased in the 
presence of sepsis: median [interquartile range] 11 [7–11] vs. 4 [2–5] μmol/l, 
P=0.016. Concentrations (in μmol/l) of other metabolites were significantly 
decreased in septic patients compared to patients without sepsis in the high SIG 
group: glutamic acid (19 [12–27] vs. 49 [28–87], P=0.016), glycolic acid (86 
[78–103] vs. 120 [100–149], P=0.037) and adipic acid (4 [2–5] vs. 7 [5–9], P=0.043).
To determine whether or not the above-mentioned metabolites contributed to the 
SIG, septic patients were compared to patients of the low SIG group. Note that 
none of the patients in the low SIG group suffered from sepsis. Concentrations of 
p-hydroxyphenyllactic acid (P=0.005) were significantly higher in patients with 
sepsis in the high SIG group compared to patients in the low SIG group and 
contributed 0.09% to the ∆SIG in these patients, corresponding to 6 μEq/l.
Furthermore, in the organic acid profile we observed a peak, co-eluting with the 
TCA cycle intermediate fumaric acid, that, by mass-spectrometric analysis, could 
Figure 3   Hydrogen-1 nuclear magnetic resonance spectrum of patient 1 that 
depicts resonances of multiple, overlapping, unidentified compounds, 
with chemical shifts between 1.2 and 1.08 ppm labeled as unknown.  
*1, mainly glucose; *2, pyruvic acid; *3, acetone; *4, threonine.
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be attributed to an antibiotic or antibiotic-derived metabolite. This peak was only 
observed in 5 patients from the high SIG group who suffered from sepsis and were 
treated with different antibiotics.
Discussion
The objective of this study was to explore the nature of ‘unmeasured’ anions by 
using different chromatography and mass spectrometry techniques, which are able 
to detect hundreds of different compounds. In addition, 1H-NMR spectroscopy was 
performed in selected samples, because this technique can identify (and quantify) 
a large range of proton containing components. Despite this elaborate attempt only 
7.9% of the difference in SIG between the low (or normal) and high SIG groups 
could be explained by the presence of high concentrations of amino acids, uric 
acid and organic acids in critically ill patients with metabolic acidosis. However, 
patients in the high SIG group indeed have significant abnormalities in concentrations 
of aminoacids and other organic acids as compared to patients in the low SIG 
group. Even though these abnormalities cannot quantitatively explain the differences 
in SIG, they do support the view that metabolic derangements exist in patients with 
high SIG. For example, concentrations of the amino acids aspartic acid, isoleucine 
and ornithine were significantly elevated in the high SIG group compared to the low 
SIG group. However, the sum of all the amino acid concentrations was not 
significantly different between the low and high SIG groups. At physiological blood 
pH, aspartic and glutamic acid are in their monovalent anion version and together 
contributed only 0.07% to the increased SIG. Their contribution in the low and high 
SIG groups was 43 and 49 μEq/l respectively. On the opposite site, the basic 
amino acids citrulline, ornithine, lysine and arginine, being monovalent cations at 
physiological blood pH, together contributed 253 and 289 μEq/l in the low and 
high SIG groups respectively. Thus, in our study, the amino acids did not contribute 
to the clarification of the SIG.
Strikingly, the amount of unidentified compounds with short elution time was 
obviously larger in the high SIG group. Not only the quantity but also the nature of 
the ninhydrine positive compounds seems to be different from that in the low SIG 
group. As these compounds elute very fast, they may contain a sulfo- or phospho-
residue. Unfortunately, we were unable to identify these compounds by 1H-NMR 
investigation. These compounds may originate from an exogenous source like 
medication or be the result of altered metabolic pathways because of the underlying 
disease process or a tissue hypoxic state.
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Total organic acids concentrations were significantly higher in the high SIG group 
and their relative contribution to the SIG was 5.6%. In our study, TCA cycle intermediate 
succinic acid was significantly elevated in the high SIG group as compared to the 
low SIG group, but accounted for only 0.07% of the increased SIG. This is in contrast 
to a recent publication that reports increased concentrations of intermediates of the 
TCA cycle in acidotic patients, which contributed on average 3 mEq/l to the 
(uncorrected) anion gap15. In that study, mean concentrations of succinic acid in 
the 4 patient groups ranged from 126 μEq/l to 358 μEq/l compared to 90 μEq/l in 
the healthy controls. Remarkably, in the control group, mean levels of succinic acid 
as well as concentrations of isocitrate and malate substantially exceeded reference 
ranges from literature20. The suggested explanation of the accumulation of TCA 
cycle intermediates by the mechanism of accelerated amino acid catabolism would 
imply distinct patterns of altered amino acid concentrations, which was not 
supported by the results of our study. Moreover, in our study, all intermediates of 
the TCA cycle quantified with 1H-NMR spectroscopy corresponded to the published 
reference ranges. Also, concentrations of isocitrate and citrate obtained by gas 
chromatography were not extremely elevated.
In our analysis of organic acids, that was limited to an analysis of compounds with 
a retention time of less than 30 minutes, we also observed the quantitatively most 
important fatty acids palmitic acid, stearic acid, oleic acid and linoleic acid. However, 
the relatively high pKa values of these fatty acids, ranging from 8.28-10.1521, preclude 
a significant contribution to the SIG.
SIG metabolic acidosis can be caused by exogenous compounds in administered 
fluids, medications and nutrients. The extent to which they contribute to the SIG is 
largely unknown. For example, gelatins, which are comprised of negatively charged 
polypeptides, are a known source of ‘unmeasured’ anions14. In our study, none of 
the patients were treated with gelatine-containing fluids. However, various drugs 
were administered to the patients in this study that may have contributed to the 
increased SIG. Many drugs derivatives will be detected in the organic acid analyses, 
but strongly polar components may remain in the water phase during extraction 
with ethylacetate. Anion-containing drugs like beta-lactam antibiotics, which are 
administered intravenously, are known to be responsible for SIG acidosis when 
they accumulate in blood due to decreased metabolic clearance. Several studies 
showed that pyroglutamic acidemia (5-oxoprolinuria) was associated with 
administration of acetaminophen and antibiotics like flucloxacillin, decreased liver 
function or glutathione reserve, sepsis and female sex12,22,23. likely, this rare cause 
of SIG acidosis is multi-factorial. In our study, it is unlikely that the administration of 
acetaminophen is a major causal factor in the presence of an increased SIG, since 
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no differences were found in acetaminophen levels between acetaminophen-treat-
ed patients from the low and high SIG group. Also, although pyroglutamic acid 
levels in the high SIG group were significantly higher, their relative contribution to 
the SIG was limited, namely 0.2%. Probably, the pyroglutamic acidemia in our 
patients is explained by multiple factors like co-administered antibiotics and 
decreased glutathione reserve. In some individuals we observed a compound 
co-eluting with fumaric acid, which corresponds to an antibiotic or an antibiotic-
derivative and was only detected in five patients from the high SIG group. The 
relative contribution of this compound to the SIG seems small (<0.5%), although 
the valency of this compound is unknown. It seems nevertheless unlikely that the 
antibiotics (or antibiotic-derivatives) contribute more than a few percent to the 
increased SIG.
Clinical and acid-base characteristics of patients in this study correspond well to 
those previously reported in literature. For example, in the high SIG group there was 
a significantly higher prevalence of sepsis and acute renal failure as compared with 
the low SIG group. This suggests that these conditions are associated with an 
increased production or decreased clearance of ‘unmeasured’ anions. Although 
we found p-hydroxyphenyllactic acid to be statistically significantly increased in 
patients with sepsis in the high SIG group as compared to patients in the low SIG 
group, this anion only accounted for 0.09% to the increased SIG. The association 
between a high SIG and renal insufficiency is well known and various so-called 
uremic compounds have been proposed to be responsible for the increase in 
SIG24. The analysis of organic acids in the present study excluded many uremic 
toxins, including orotic acid, oxalic acid, kynurenic acid and thymine, as major 
contributors to the increased SIG. Uric acid is a water soluble low molecular weight 
solute and potent uremic toxin, which was significantly elevated in the high SIG 
group compared to the low SIG group. As a single compound, uric acid was 
responsible for the largest relative contribution to the SIG, namely 2.2%. The content 
of positive charges caused by creatinine in its form of monovalent creatininium ions 
was higher in the high SIG group than the low SIG group (217 vs 84 μEq/l). The 
effect of these ‘unmeasured’ cations is a reduction of the relative contribution of the 
measured anions in our study to the SIG. Although our study is not designed to 
establish the prognostic value of the presence of a high SIG in acidotic ICU patients, 
the higher mortality in this group (33 vs 0%) is evident. This observation is in 
agreement with a recently published study10 that reports a better discriminating 
power of a high SIG (>5 mEq/l) for mortality than other established outcome 
predicters like lactate and Injury Severity Score.
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Because our study aimed to identify ‘unmeasured’ anions in a general group of 
critically ill acidotic patients, we did not select patients with a special diagnosis or 
condition other than metabolic acidosis. This implies that a fairly large variety of 
different causes potentially determined the increase in SIG. Because of this 
heterogeneity, relevant elevations of one or more random compounds in one 
patient may go unnoticed. For example, an extremely high concentration of the 
ketone body 3-hydroxybutyric acid was only noticed in one patient. Nevertheless, 
no high concentrations were observed for any of the other quantified acids in any 
patient, which makes it unlikely that measured anions which would contribute 
substantially to the SIG were missed.
In conclusion, the present study demonstrates that amino acids, uric acid and 
organic acids together accounted for only 7.9% of the SIG in ICU patients with a 
metabolic acidosis. This study excludes many potent ‘unmeasured’ anions as 
major contributors of the SIG. The variety in significantly elevated anions in the 
presence of a high SIG may be indicative of several concomitant etiologies of 
strong ion gap metabolic acidosis.
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CHAPTER 4
Summary
Purpose Urinary excretion of chloride corrects metabolic acidosis, but this may be 
hampered in patients with impaired renal function. We explored the effects of renal 
function on acid-base characteristics and urinary strong ion excretion using the 
Stewart approach in critically ill patients with metabolic acidosis.
Materials and Methods We examined the plasma and urine chemistry in 65 critically 
ill (mixed medical and surgical) patients with metabolic acidosis. The apparent 
strong ion difference, effective strong ion difference, strong ion gap, and urinary 
simplified strong ion difference (urinary SID) were calculated. linear regression 
analyses were used (1) to assess whether plasma creatinine concentrations were 
related to urinary SIDs values, adjusted for blood pH levels, and (2) to determine 
whether urinary SID values were associated with blood pH levels.
Results Creatinine concentrations were positively and significantly (P<0.001) 
associated with urinary SIDs values, adjusted for pH levels. Urinary simplified 
strong ion difference values were inversely and significantly (P<0.001) related to 
pH levels.
Conclusions In critically ill patients with metabolic acidosis, impaired renal function 
was associated with greater urinary SIDs. Subsequently, the higher urinary SIDs 
values were related to lower pH levels, illustrating the importance of renal chloride 
excretion to correct for acidosis.
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Introduction
Metabolic acidosis is a frequent disorder in intensive care unit (ICU) patients that 
contributes to mortality1. The quantitative physicochemical approach to acid-base 
disorders originally described by Stewart2 states that ionic charge equivalence 
influences acid-base chemistry. The apparent strong ion difference (SIDapp) is the 
difference between the main strong cations and anions concentrations measured 
in plasma. The effective strong ion difference (SIDeff) is determined by the 
contribution of weak acids to the electrical charge equilibrium in plasma. The 
difference between the SIDapp and SIDeff, the strong ion gap (SIG), should equal 
zero. A positive value for the SIG indicates the presence of unmeasured strong 
anions. According to the Stewart approach, only 3 factors independently influence 
pH, namely, the SIDapp value, PaCO2, and the concentration of weak acids3,4. The 
factors that contribute to metabolic acidosis and are specific for acute renal failure 
(ARF) in ICU patients are lower SIDapp values, higher SIG values, and higher 
concentrations of the weak acid phosphate4. Applying the physicochemical 
principles of Stewart, the primary defense mechanism against acidosis in healthy 
subjects is increasing their SIDapp values by renal excretion of chloride without a 
strong cation4,5. The importance of this mechanism and how it is influenced by 
renal function in critically ill patients is unknown. We hypothesized that, in critically 
ill patients with renal dysfunction and metabolic acidosis, impaired urinary excretion 
of the strong anion chloride contributes to acidosis.
Methods
Study population
This prospective observational study was conducted in a multidisciplinary ICU. The 
local medical ethical committee waived the need for informed consent. Sixty-five 
consecutive, adult, critically ill patients with a metabolic acidosis defined as pH less 
than 7.35 and base excess (BE) of −5 or less, present at admission or developed 
during their stay, were enrolled. Acute Physiology and Chronic Health Evaluation 
(APACHE) II data were collected for the first 24 hours after admission.
Fluid resuscitation was performed by discretion of the treating physician with 
isotonic saline or short-acting starch products (sodium and chloride concentration 
154 mmol/l). 
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Measurements
In each patient, a single arterial blood sample was collected. In this sample, pH, 
partial pressures of oxygen and carbon dioxide (PaO2 and PaCO2), and plasma 
concentrations of ionized calcium and lactate were measured on a blood gas 
analyzer (Rapidlab; Bayer Diagnostics, Breda, The Netherlands). Plasma concentrations 
of sodium, potassium, and chloride were analyzed using an ion-selective electrode 
on an Aeroset (Abbott Diagnostics, Hoofddorp, The Netherlands); and plasma 
concentrations of magnesium, creatinine (in micromole per liter), urea, phosphate, 
and albumin were measured on an Aeroset. Bicarbonate was calculated using the 
Henderson-Hasselbalch equation (pH=6.1+log ([HCO3–] /0.0301 PaCO2) and the 
standard base excess (SBE) using the Siggaard-Andersen formulae. The apparent 
(SIDapp = [Na+]+[K+]+[Ca2+]+[Mg2+]–[Cl–]–[lactate–]) and effective strong ion 
difference (SIDeff = (2.46 x 10-8 x PaCO2 /10-pH) + ([albumin] x 0.123 x (pH – 0.631)) 
+ ([phosphate] x (0.309 x pH – 0.469)) and strong ion gap (SIG = SIDapp – SIDeff) 
were calculated.
In addition, the plasma simplified SID (plasma SIDs) was calculated: [Na+] −[Cl−] 
in plasma. All mentioned concentrations are expressed in milliquivalent per liter, 
except for the concentrations of albumin (gram per liter), phosphate (millimole per 
liter) and PaCO2 (millimeters of mercury).
The main urinary strong ions sodium and chloride were measured in a single urine 
sample on an Aeroset at the time of blood gas analysis. Subsequently, the urinary 
simplified strong ion difference (urinary SIDs) (milliequivalent per liter) was 
calculated: [Na+] − [Cl–].
Statistical analysis
Continuous variables were described by the mean and SD or the median and 
interquartile range (IQR) for variables with skewed distributions. logistic regression 
was used to estimate the association between plasma creatinine concentrations 
and sepsis status. Multivariate linear regression analysis was performed to 
determine whether plasma creatinine concentrations (the independent variable as 
a measure of renal function) were related to urinary SIDs values (as a measure of the 
net urinary charge excretion of the main strong ions sodium and chloride). The 
model was adjusted for the potential confounder blood pH level. We hypothesized 
lower pH levels to be related to declined renal function and, second, to increase 
renal chloride excretion to elevate the plasma SIDapp value and normalize the pH 
level6. To satisfy the statistical assumptions of the regression model, both 
independent variables were natural log transformed to achieve normal distributions 
using the lnskew0 function in Stata. This yielded the following equations: (a) the 
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log-transformed plasma creatinine concentration = ln(plasma creatinineconcen-
tration − 34.0) and (b) the log-transformed blood pH level = −ln(−blood pH level 
+ 7.35). In addition, we further adjusted the model for the potential confounders 
plasma SIDapp, plasma simplified SID, and plasma SIG values separately because 
they may be related to renal function and the urinary excretion of chloride.
To assess whether urinary SIDs values were related to blood pH levels, simple linear 
regression analysis was applied. The urinary SIDs values were natural log 
transformed to achieve a normal distribution using the lnskew0 function in Stata: –
ln(–urinary SIDs value + 42.5). To characterize the relation between plasma 
creatinine concentrations and determinants of blood pH levels, the Spearman rank 
correlation (rS) was used. The relations were presented by box plots with plasma 
creatinine cutoff values of 100, 200, and 300 μmol/l, which we defined before 
conducting the analysis. In addition, multivariate linear regression analyses were 
used to examine whether creatinine concentrations were associated with SIDapp 
values independently of pH levels and, second, to assess whether creatinine 
concentrations were related to SIG values independently of the presence of sepsis.
All analyses were performed with the use of Stata software, version 10.1 (StataCorp 
lP, College Station, Tex). P<0.05 was considered statistically significant, and 
2-sided tests of hypotheses were used throughout.
Results
Clinical characteristics and laboratory parameters
The characteristics of the ICU patients, with metabolic acidosis, are summarized in 
Table 1. Patients were aged between 17 and 90 years and APACHE II scores ranged 
from 7 to 43. Patients were predominantly diagnosed with sepsis. In Table 2 the 
laboratory parameters are presented. The difference between the 25th and 75th 
percentiles of the creatinine concentrations was approximately 140 μmol/l. In the 
logistic-regression analysis, concentrations of plasma creatinine were a positive 
predictor of sepsis (odds ratio per 140 μmol/l increase in creatinine values: 2.87; 
95% confidence interval (CI): 1.36, 6.07; P<0.01).
Association between renal function and urinary simplified SID values
In the linear regression model of the urinary SIDs, the log transformed plasma 
creatinine concentrations (β coefficient: 16.6; 95% CI: 7.7, 25.5; P<0.001) were 
positively and significantly associated with urinary SIDs values, adjusted for log 
transformed blood pH levels. The correlation between the independent variables in 
the regression model did not reach statistical significance (P=0.06). Figure 1 
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illustrates the relation between the measured creatinine and urinary SIDs values, 
and the estimated relation between these variables according to the regression 
model. After further adjusting the regression model for plasma SIDapp and plasma 
simplified SID values separately, the log transformed creatinine concentrations 
remained positively and significantly related to urinary SIDs values. Adjustment for 
plasma SIG values resulted in a borderline significant (P=0.07) positive association 
between log transformed creatinine concentrations and urinary SIDs values.
Association between urinary simplified SID values and pH levels
In the linear regression model of blood pH, the log transformed urinary SIDs values 
(–0.090; 95% CI: –0.134, –0.046; P<0.001) were inversely and significantly related 
to pH levels. Figure 2 shows the relation between the measured urinary SIDs and 
pH values, and the estimated relation between these variables according to the 
regression model.
Table 1   Demographic, Clinical and Outcome Data of ICU Patients with 
Metabolic Acidosis
Variable n (%)
N 65
Age (yr)* 70 (57-75)
Sex [male] 35 (54%)
APACHE II score* 19 (16-26)
Mortality 21 (32%)
Diagnosis
   Sepsis 24 (37%)
   Trauma / bleeding 10 (15%)
   Cardiogenic shock 14 (22%)
   Surgical 10 (15%)
   Other 7 (11%)
* Results of this variable are presented as median (interquartile range).
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Associations between creatinine concentrations and determinants 
of pH levels
Creatinine concentrations were positively associated with: plasma SIDapp values 
(rS=0.36; p<0.01), concentrations of the weak acid phosphate (rS=0.57; P<0.0001) 
and plasma SIG values (rS=0.50; P<0.0001; all in mEq/l). Box plots of these 
relations are shown in Figure 3. After adjusting for blood pH levels, creatinine 
concentrations remained positively and significantly related to SIDapp values, as 
estimated by the linear regression model. In the linear regression model of the 
plasma SIG, creatinine concentrations remained positively associated with SIG 
values (P<0.001), after adjustment for sepsis status (P=0.92). Furthermore, 
creatinine concentrations were inversely related to concentrations of plasma 
chloride (rS= −0.59; P<0.0001; mmol/l).
Table 2   laboratory Parameters in ICU Patients with Metabolic Acidosis
Variable Median IQR Range
Creatinine (μmol/l) 153 92-234 50-602
pH 7.28 7.21- 7.31 6.91-7.34
SBE (mmol/l) −9 −11 to−6 −25 to −5
PaCO2 (mm Hg) 39 35-43 22-74
Sodium (mmol/l or mEq/l)* 138 ± 5 124-149
Potassium (mmol/l or mEq/l)* 4.2 ± 0.7 1.7-6.0
Chloride (mmol/l or mEq/l) 113 110-117 93-124
lactate (mmol/l or mEq/l) 2.1 1.4-3.0 0.8 -11.8
SIDapp (mEq/l) 29 27-33 20-44
Albumin (g/l) 16 13-18 6-34
Phosphate (mmol/l) 1.1 1.0-1.7 0.4-2.7
SIDeff (mEq/l) 25 21-27 11-30
SIG (mEq/l) 5.6 3.7-8.0 −1.9 to 16.1
Urinary sodium (mmol/l or mEq/l) 51 20-85 5-168
Urinary chloride (mmol/l or mEq/l) 75 32-110 14-192
Urinary SIDs (mEq/l) −12 −29 to −3 −152 to 29
SBE indicates standard base excess * Results of this variable are presented as mean ± SD and range. 
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Figure 1   Scatterplot of the measured plasma creatinine concentrations and 
urinary simplified strong ion differences (SIDs) overlayed with the 
estimated relation between these variables according to the linear 
regression model, for blood pH levels of 7.16, 7.28 and 7.33, which are 
the 10th percentile, median and 90th percentile of the pH distribution, 
respectively. The point estimates of the associations and, for the 
median pH value, also the 95% CI limits of the point estimate are 
presented.
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Figure 2   Scatterplot of the measured urinary simplified strong ion differences 
(SIDs) and blood pH levels, overlayed with the estimated relation 
between these variables according to the linear regression model.  
The relation is presented by the point estimate and its 95% CI limits. 
Only ICU patients with pH levels lower than 7.35 (see reference line) 
were included in the study.
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Figure 3   Box plots of A) plasma SIDapp values, B) concentrations of the weak 
acid phosphate, and C) plasma SIG values (all in mEq/l) for plasma 
creatinine concentration groups with cutoff values of 100, 200 and  
300 μmol/l.
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Discussion
In this study, we examined the effect of renal function on urinary strong ion excretion 
and plasma acid-base status in critically ill patients with metabolic acidosis. In these 
patients, higher plasma creatinine concentrations were significantly associated 
with greater urinary simplified SID values. Subsequently, greater urinary SIDs values 
were significantly related to lower blood pH levels. Therefore, less urinary strong 
anion excretion during impaired renal function appears to represent a determinant 
of the metabolic acidosis in these patients.
The kidney plays a central role in the body’s handling of chloride and sodium. In 
normal subjects, 80% of the sodium filtered by the glomerulus is resorbed with 
chloride and 20% is exchanged for potassium and hydrogen which allows chloride 
clearance7. During metabolic acidosis the absolute renal chloride clearance (by 
co-excretion with NH4+ produced by metabolism of glutamine) should increase6. In 
this way, every chloride ion filtered, but not reabsorbed, increases the plasma SID3 
and subsequently corrects acidosis. Accordingly, in our sample, less strong anion 
excretion during impaired renal function is probably caused by impaired NH4+ 
generation from glutamine metabolism. Thus, this probably reflects an inadequate 
Figure 3   Continued.
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renal chloride excretion in response to acidosis. This was previously described in 
patients with chronic renal failure and distal renal tubular acidosis8, but to our 
knowledge, not in critically ill patients in relation to renal function.
Theoretically, the significantly greater urinary SIDs values in relation to declined 
renal function in our study may also partly reflect greater renal excretion of 
unmeasured anions, as higher plasma SIG values (as a result of extra renal causes 
such as sepsis or keto-acidosis) may result in more negatively charged glomerular 
filtrates because of filtered unmeasured anions. As a result, the excretion of chloride 
ions may be hampered for a given renal function. However, our observation of 
higher SIG values in association with impaired renal function is most likely the 
consequence of an attenuated urinary excretion of unmeasured anions. Therefore, 
it appears unlikely that unmeasured anions in the urine account for the impaired 
urinary excretion of chloride in patients with impaired renal function. In addition, the 
confounding effect of the plasma SIG was assessed and only slightly attenuated 
the estimated effect of renal function on the urinary SIDs in our sample.
Quantitative plasma analysis of the variables that independently determine the pH 
level revealed two other points. First, the significantly higher SIG and weak acid 
phosphate values in patients with higher creatinine concentrations accounted for a 
greater acidifying effect. This finding is consistent with a previous report that 
compared ICU patients with acute renal failure with ICU controls without ARF4. As 
discussed above, the significantly greater SIG values in association with declined 
renal function in our study may be explained by a decreased renal clearance of 
unmeasured anions. A possible candidate is sulphate, as described in prior 
studies9,10. Although sepsis has been associated with the appearance of strong 
ions in several reports11,12, in our study, the presence of sepsis was not associated 
with higher SIG values for a given creatinine concentration. This may indicate that 
increased plasma SIG values in ICU patients with sepsis are primarily caused by 
impaired renal function. Second, plasma SIDapp values were significantly higher in 
patients with declined renal function. Still, the SIDapp values in our study sample 
(range: 20 to 44 mEq/l) were lower than SIDapp values reported in non-acidotic ICU 
controls (mean ± SD: 45±4 mEq/l)4 and SIDapp values in normal subjects (42±2 
mEq/l)12. As higher levels of plasma SIDapp and simplified SID may in itself increase 
the urinary SIDs value, the relation between plasma creatinine and urinary SIDs 
values was adjusted for the plasma SIDapp and simplified SID values separately, in 
addition to the adjustment for pH levels. The correction for plasma simplified SID 
values only slightly attenuated the estimated effect of renal function on urinary SIDs 
values. However, adjustment for SIDapp values did not alter the relation to a relevant 
extent.
67
ImpaIred renal functIon Is assocIated wIth greater urInary strong Ion dIfferences
4
Our observation of significantly higher plasma SIDapp values and significantly lower 
plasma chloride concentrations in relation to declined renal function can only be 
explained by a less liberal fluid policy in patients with elevated creatinine 
concentrations, given their impaired chloride excretion. No specific protocol for 
fluid treatment was prescribed and balanced solutions were not used at the time. 
Our study was not aimed at addressing the effects of volume and composition of 
fluid therapy on acid-base chemistry in relation to renal function. Therefore, data on 
fluid, sodium and chloride intake and output were not recorded.
Two other limitations of our study should be addressed. First, we defined renal 
function as a single measurement of the plasma creatinine concentration and not 
as the actual glomerular filtration rate (GFR). However, the logarithmic relation 
between urinary SIDs values and creatinine concentrations resembles the relation 
between GFR and creatinine concentrations. This suggests a linear relation 
between GFR and the renal capacity to excrete strong anions. Second, we defined 
the urinary simplified SID as the difference between urinary sodium and chloride 
concentrations, not taking into account other electrolytes in the urine. We feel this 
simplification is justified, because sodium and chloride are the most abundant 
strong ions in the extracellular compartment and, therefore, the most important 
determinants of the strong ion difference13,14. Because plasma sodium controls 
intravascular volume and osmolality and given that plasma potassium is important 
for cardiac and neuromuscular function, plasma chloride appears to represent the 
strong ion that the kidney uses to regulate acid-base status without interfering with 
other important homeostatic processes. In accordance, using urinary chloride 
alone instead of the urinary simplified SID in examining the effect of renal function 
on urinary chloride excretion yielded similar results (data not shown). Despite these 
limitations, to our knowledge, our study is the first to examine urinary strong ion 
excretion and acid-base status in relation to renal function in critically ill patients.
In conclusion, declined renal function was associated with greater urinary simplified 
strong ion differences in critically ill patients with metabolic acidosis. Subsequently, 
higher urinary simplified SID values were associated with lower blood pH levels. 
This may suggest that in critically ill patients with metabolic acidosis impaired renal 
function is related to the urinary excretion of inadequate amounts of plasma chloride 
to correct for acidosis. Accordingly, chloride loading by means of massive 
unbalanced volume resuscitation may lead to more pronounced acidosis in these 
patients.
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Summary
Introduction Metabolic alkalosis is a commonly encountered acid-base derangement 
in the ICU. Treatment with the carbonic anhydrase inhibitor acetazolamide is indicated 
in selected cases. According to the quantitative approach described by Stewart, 
correction of serum pH due to carbonic anhydrase inhibition in the proximal tubule 
cannot be explained by excretion of bicarbonate. Using the Stewart approach, we 
studied the mechanism of action of acetazolamide in critically ill patients with a 
metabolic alkalosis.
Methods Fifteen consecutive ICU patients with metabolic alkalosis (pH ≥ 7.48 and 
HCO3 ≥ 28 mmol/l) were treated with a single administration of 500 mg acetazolamide 
intravenously. Serum levels of strong ions, creatinine, lactate, weak acids, pH and 
PaCO2 were measured at 0, 12, 24, 48 and 72 hours. Main strong ions of the urine 
and pH were measured at 0, 3, 6, 12, 24, 48 and 72 hours. Apparent strong ion 
difference (SIDapp), strong ion gap, sodium-chloride effect and the urinary SID were 
calculated. Data were analyzed by comparing baseline variables and the time 
dependent changes by one way analysis of variance for repeated measures.
Results After a single administration of acetazolamide, correction of serum pH 
(from 7.49 ± 0.01 to 7.46 ± 0.01; P=0.001) was maximal at 24 hours and sustained 
during the period of observation. The parallel decrease in partial carbon dioxide 
tension was not significant (from 5.7 ± 0.2 to 5.3 ± 0.2 kPa; P= 0.08) and there was 
no significant change in total concentration of weak acids. Serum SIDapp decreased 
significantly (from 41.5 ± 1.3 to 38.0 ± 1.0 mEq/l; P= 0.03) due to an increase in 
serum chloride (from 105 ± 1.2 to 110 ± 1.2 mmol/l; P< 0.0001). The decrease in 
serum SIDapp was explained by a significant increase in the urinary excretion of 
sodium without chloride during the first 24 hours (increase in urinary SID: from 48.4 
± 15.1 to 85.3 ± 7.7; P= 0.02).
Conclusions A single dose of acetazolamide effectively corrects metabolic alkalosis 
in critically ill patients by decreasing the serum SIDapp. This effect is completely 
explained by the increased renal excretion ratio of sodium to chloride, resulting in 
an increase in serum chloride.
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Introduction
Metabolic alkalosis is a common acid–base disturbance in the intensive care unit 
(ICU) that is associated with increased ICU mortality and morbidity1,2, with adverse 
effects on cardiovascular, pulmonary and metabolic function3,4. Additionally, such 
patients are characterized by compensatory alveolar hypoventilation, which can 
result in delayed weaning from mechanical ventilation. Options for treatment aimed 
at correcting metabolic alkalosis are fluid and potassium replacement, and 
administration of ammonium chloride, hydrochloric acid, or acetazolamide5. These 
therapeutic interventions potentially increase minute ventilation, allowing patients 
to be weaned more rapidly6. 
An advanced understanding of acid–base physiology is central to the practice of 
critical care medicine. Although it is not difficult to quantify the degree of metabolic 
alkalosis, it is more challenging to identify the cause of a metabolic alkalosis and 
determine the actions that must be taken to correct it. The method of quantifying 
and qualifying an acid–base disturbance, as described by Stewart, relies on the 
accepted physicochemical principles of conservation of mass and electroneutrali-
ty7,8. According to Stewart, three variables independently determine the serum 
hydrogen concentration. These variables are the partial carbon dioxide tension 
(PaCO2), the total concentration of nonvolatile weak acids (primarily serum proteins 
and phosphate), and the apparent strong ion difference (SIDapp)9. The Stewart 
approach, in contrast to other approaches, allows us to quantify an acid–base 
derangement as well as determine its cause.
The kidneys are the most important regulators of SIDapp for acid–base purposes. 
The concentration of strong ions in plasma can be altered by adjusting absorption 
from glomerular filtrate or secretion into the tubular lumen from plasma. In this 
respect, administration of the carbonic anhydrase inhibitor acetazolamide during 
metabolic alkalosis could modulate plasma pH by influencing the urinary excretion 
of various strong ions. Because plasma sodium controls intravascular volume and 
osmolality, and because plasma potassium is important for cardiac and neuromuscular 
function, plasma chloride appears to represent the strong ion that the kidney uses 
to regulate acid–base status without interfering with other important homeostatic 
processes7. Furthermore, the basic physicochemical principles imply that a change 
in bicarbonate concentration is not a cause but merely a co-phenomenon of an 
acid–base disturbance such as metabolic alkalosis.
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Acetazolamide decreases proximal tubular bicarbonate reabsorption by up to 80% 
through inhibition of carbonic anhydrase in the luminal borders of renal proximal 
tubule cells, and it is often effectively used in the treatment of metabolic alkalosis in the 
ICU. However, the mechanism of action of acetazolamide remains unclear. According 
to the basic physicochemical principles mentioned above, retention of bicarbonate 
cannot causally be related to correction of serum pH, and acetazolamide- induced 
effects must be explained by modulation of the urinary excretion of strong ions.
We hypothesized that acetazolamide, by inhibiting carbonic anhydrase in the 
proximal tubules, causes excretion of strong cations (along with bicarbonate) and 
retention of chloride, and in this way decreases the serum SIDapp. Subsequently, 
the decrease in SIDapp will correct an alkalosis by causing dissociation of water and 
formation of hydrogen ions. The purpose of the present study was to determine the 
mechanism of action of acetazolamide in critically ill patients with a metabolic 
alkalosis according to the physicochemical principles described by Stewart.
Methods
Patients
The local ethics committee granted approval for the study and, because the 
indication for acetazolamide was based on clinical grounds, waived the need for 
informed consent. This prospective study was set in the multidisciplinary ICU of the
Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands.
We studied 15 consecutive ICU patients with a metabolic alkalosis (defined as pH ≥ 
7.48) and serum bicarbonate of 28 mmol/l or greater. All patients had an arterial line 
in situ. Patients clinically suspected of having volume contraction (for example cold 
extremities, blood pressure increase during passive leg raising), hypokalaemia serum 
potassium ≤ 3.4 mmol/l), nasogastric tube drainage greater than 50 cc/hour, renal 
insufficiency (creatinine clearance <20 ml/min and/or renal replacement therapy), or 
intolerance or allergy to acetazolamide or sulfonamides were excluded. Also excluded 
were patients who were treated with intravenous acetazolamide or sodium bicarbonate 
during the previous 72 hours. Acute Physiology and Chronic Health Evaluation II 
score was calculated and recorded for each patient for the first 24 hours after 
admission. Data on fluid intake and output, ventilator settings, and relevant medications 
such as diuretics and steroids were also recorded. After inclusion, patients received 
a single dose acetazolamide (500 mg as an intravenous push).
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Experimental design
We measured pH, arterial oxygen tension, arterial PCO2 (PaCO2), sodium, potassium, 
chloride, magnesium, calcium, lactate, creatinine, urea, phosphate and albumin in 
a single arterial blood sample before acetazolamide was administered (t = 0) and 
12, 24, 48 and 72 hours later (t = 12, t = 24, t = 48 and t = 72). Urine samples were 
taken before acetazolamide was administered, and 3, 6, 12, 24, 48 and 72 hours 
later. In these samples pH was measured immediately. Urine was stored at -80°C, 
and sodium, chloride, potassium and creatinine were measured in a single batch at 
the end of the study.
Data analysis, calculations and statistics
Bicarbonate was calculated using the Henderson–Hasselbalch equation (pH = 6.1 
+ log [HCO3-]/0.0301 x PaCO2]) and the standard base excess was calculated 
using the Siggaard–Andersen formula. The apparent SID (SIDapp) was calculated 
using the equation SIDapp = [Na+] + [K+] + [Ca2+] + [Mg2+] - [Cl-] - [lactate-]. The 
effective SID (SIDeff) was calculated using the equation SIDeff = (2.46 x 10-8 x PaCO2 
(mm Hg)/10-pH) + ([albumin in g/l] x 0.123 x (pH – 0.631)) + ([phosphate in mmol/l] 
x (0.309 x pH – 0.469)). The strong ion gap (SIG) was calculated using the equation 
SIG = SIDapp - SIDeff10. The sodium–chloride effect was calculated using the 
formula [Na+]- [Cl-] - 3811. Urinary electrolytes to creatinine ratios and sodium to 
chloride ratios were calculated, as was the urinary SID using the following equation: 
urinary SID = [Na+] + [K+] - [Cl-].
The effects of acetazolamide were analyzed by comparing baseline variables 
and time-dependent changes using oneway analysis of variance with repeated 
measures. Power analysis was based on a presumed standard deviation of 15% 
for the measured end-points. A change of 10% was considered clinically relevant. 
With α = 0.05, we calculated that a sample size of 14 would be needed to achieve 
a power of 80%. Therefore, 15 patients were included.
Data are expressed as mean ± standard error unless otherwise specified. P< 0.05 
was considered statistically significant.
Results
Patients
Patient characteristics are presented in Table 1, and baseline acid–base and electrolyte 
data are presented in Table 2. Of the patients studied, 87% were mechanically 
ventilated (all in an assisted mode of ventilation in which spontaneous breathing 
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activity was fully possible). Although 47% of the patients were treated with diuretics, 
none exhibited clinical symptoms of hypovolaemia. Furthermore, low urinary chloride 
excretion (< 20 mmol/l), which is indicative of hypovolaemia in patients who do not 
use diuretics, was present in only one patient.
Intravenous and enteral intake of sodium chloride, as well as ventilator settings and 
diuretic dose, were not changed during the study period.
Effects of acetazolamide on Stewart’s parameters in blood
After administration of acetazolamide, correction of serum pH (7.49 ± 0.01 to 7.46 
± 0.01; P= 0.001) was maximal at 24 hours and was sustained during the period of 
observation (Figure 1). The parallel decrease in PaCO2 was not significant (from 5.7 
± 0.2 to 5.3 ± 0.2 kPa; P= 0.08). There was no significant change in the total 
concentration of weak acids. When values of weak acids were expressed as values 
contributing to the electrical charge equilibrium in plasma (see formula for SIDeff), 
phosphate decreased from 2.14 ± 0.11 mEq/l to 1.94 ± 0.10 mEq/l (P= 0.02), 
and albumin remained unchanged (from 4.65 ± 0.30 mEq/l to 4.87 ± 0.35 mEq/l; 
Table 1   Patient characteristics
Characteristic Value
Age (years; mean [range]) 67 (35-79)
Sex (male/female; n) 10/5
APACHE II score (mean [range]) 21 (12-30)
Mechanical ventilation (%) 87
Diuretics (%) 47
Standardized mortality ratio 0.57
Hospital mortality (%) 20
Diagnosis
     Dissecting/ruptured aorta 2
     Postoperative bleeding 2
     Sepsis 4
     Open heart surgery 4
     Cardiogenic shock 1
     Neurological disease 2
Shown are demographic data of all patients. APACHE: Acute Physiology and Chronic Health Evaluation
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P= 0.15; Figure 1). Serum SIDapp decreased significantly during the period of 
observation (from 41.5 ± 1.3 mEq/l to 38.0 ± 1.0 mEq/l; P= 0.03) because of an 
increase in serum chloride (from 105 ± 1.2 mmol/l to 110 ± 1.2 mmol/l; P< 0.0001, 
figure 2). There was a strong relation between the serum SIDapp and the sodium–
chloride effect (R2= 0.99; P< 0.001), indicating that the observed changes in SIDapp 
are completely accounted for by changes in serum sodium and/or chloride and not 
other strong ions. The decrease in serum SIDapp was caused by a significant increase 
in the urinary excretion of sodium without chloride during the first 24 hours (change 
in urinary [Na]/[Cl]: from 1.3 ± 0.3 to 2.5 ± 0.5; P= 0.02), resulting in an increase in 
urinary SID (see Effects of acetazolamide on Stewart’s parameters in urine, below). 
In the patients studied here, there was no relevant SIG (mean baseline value 2.11 ± 
0.81 mEq/l), and it exhibited no change after administration of acetazolamide (3.13 
± 0.48; P= 0.43).
Table 2   Acid-base and electrolyte data
Acid-base and electrolyte data Baseline T=24
pH 7.49 (7.48-7.51) 7.46 (7.44-7.48)
PaCO2 (kPa) 5.7 (5.1-6.1) 5.3 (4.9–5.9)
Bicarbonate (mmol/l) 31.5 (29.5–33.7) 28.6 (26.3–30.3)
Sodium (mmol/l) 141 (139–145) 142 (139–145)
Potassium (mmol/l) 3.7 (3.7–4) 3.8 (3.4–3.9)
Chloride (mmol/l) 106 (102–107) 108 (107–110)
Creatinine (μmol/l) 64 (49–95) 65 (49–101)
lactate (mmol/l) 1.4 (1.2–1.8) 1.5 (1.2–1.7)
Albumine (g/l) 16 (14–20) 17 (15–20)
SIDapp (mEq/l) 41.7 (39.1–44.0) 39.4 (36.4–41.4)
SIDeff (mEq/l) 39.0 (37.3–40.3) 35.6 (32.9–37.7)
SIG (mEq/l) 2.4 (1.5–4.4) 3.1 (2.1–4.8)
Sodium-chloride effect (mEq/l) -2.0 (-3.5 to +0.5) -3.0 (-7.5 to -1.5)
Shown are baseline acid–base and electrolyte data (median [interquartile range]) for 15 patients 
before administration of 500 mg acetazolamide (baseline) and after 24 hours (t = 24). The serum 
apparent SID (SIDapp) was calculated using the following equation: [Na+] + [K+] + [Ca2+] + [Mg2+] - 
[Cl-] - [lactate-]. The serum effective SID (SIDeff) was calculated using the equation SIDeff = (2.46 x 10-8 
x PaCO2 (mm Hg)/10-pH) + ([albumin in g/l] x 0.123 x (pH – 0.631)) + ([phosphate in mmol/l] x (0.309 
x pH – 0.469)). The strong ion gap (SIG) was calculated using the following equation: SIG = SIDapp - 
SIDeff . The sodium–chloride effect was calculated using the formula [Na+] - [Cl-] - 38. PaCO2: arterial 
carbon dioxide tension; SID: strong ion difference; SIG: strong ion gap.
80
CHAPTER 5
Effects of acetazolamide on Stewart’s parameters in urine
Urinary pH increased significantly from 5.55 ± 0.26 to 6.13 ± 0.37 (P= 0.005) 
during the first 12 hours after administration of acetazolamide, and returned to pre-
administration value during the next 60 hours (Figure 3). Urinary SID exhibited a 
Figure 1   Time course of acetazolamide-induced changes in pH and three 
independent variables that determine pH.
Effect of 500 mg acetazolamide administration (intravenous) in patients with metabolic alkalosis. Data are 
expressed as mean ± standard error values for 15 patients. The P values refer to the time-dependent 
changes analyzed using one-way analysis of variance. PaCO2: partial carbon dioxide tension; SIDapp: 
apparent strong ion difference.
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parallel increase (from 48.4 ± 15.1 to 85.3 ± 7.7; P= 0.02) during the first 12 hours 
and a parallel decrease thereafter. 
Figure 2   Time course of acetazolamide-induced changes in serum potassium, 
sodium and chloride.
Effect of 500 mg acetazolamide administration (intravenous) in patients with metabolic alkalosis. Serum 
chloride exhibited a significant increase, whereas there were no significant changes in serum potassium 
and sodium concentration. Data are expressed as mean ± standard error values for 15 patients. The P 
values refer to the time-dependent changes analyzed using one-way analysis of variance.
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Discussion
Our study is the first to demonstrate that the acetazolamide-induced correction of 
metabolic alkalosis in critically ill patients can completely be accounted for by a 
significant decrease in serum SIDapp, using the physicochemical principles 
described by Stewart. Although analysis using the Henderson–Hasselbalch 
equation is useful for describing and classifying acid–base disorders, the physico-
chemical approach described by Stewart is better suited to quantifying these 
disorders and for generating hypotheses regarding mechanisms.
Use of the Stewart model has improved our understanding of the pathophysiology 
that leads to changes in acid–base balance. SIDapp, total concentration of 
nonvolatile weak acids, and PaCO2 are biological variables that are regulated 
mainly by renal tubular transport, metabolism and ventilation. The relative complexity 
Figure 3   Effect acetazolamide on urinary pH and sodium-chloride ratio.
Effect of 500 mg acetazolamide administration (intravenous) in patients with metabolic alkalosis. Data are 
expressed as mean ± standard error values for 15 patients. The P values refer to the time-dependent 
changes analyzed using one-way analysis of variance.
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of the Stewart approach comes from the fact that several variables are needed. 
However, when these variables are absent or assumed to be normal, the approach 
becomes essentially indistinguishable from the more traditional descriptive 
methods. For example, our study does not dispute the contention that acetazolamide, 
through inhibition of carbonic anhydrase in the proximal tubule, increases urinary 
bicarbonate excretion. However, according to the Stewart approach it is not the 
loss of bicarbonate that determines the fall in pH, because bicarbonate is not an 
independent parameter. According to Stewart, it is the change in SIDapp (due to a 
rise in chloride) that explains the decrease in pH. In our patients, acetazolamide-
induced loss of bicarbonate facilitated the renal reabsorption of chloride, while 
sodium could still be excreted. In other words, acetazolamide-induced bicarbonate 
excretion permits urinary excretion of sodium without loss of any strong anions, 
resulting in a lower SIDapp and thereby a decrease in pH.
Apart from the acetazolamide-induced change in SIDapp, our study demonstrates 
that inhibition of carbonic anhydrase does not significantly alter the other 
independent determinants of serum pH. In contrast, the non-significant decrease 
in PaCO2 and small decrease in weak acid phosphate cause the opposite effect 
on serum pH. The small decrease in PaCO2 in our patients can be explained by 
an increase in minute ventilation in response to correction of serum pH by aceta-
zolamide. This increase in minute ventilation, as a result of an increased respiratory 
drive, was possible in an assisted mode of mechanical ventilation. Finally, the 
observed small increase in serum albumin does not have a significant lowering 
effect on serum pH and could probably be explained by the hemo-concentrating 
effect of diuretics during the study period.
The acetazolamide-induced decrease in SIDapp is entirely caused by a change in 
serum concentration of chloride, as shown by the strong relation between the 
SIDapp and the sodium–chloride effect. These changes in sodium and chloride are 
explained by an increase in urinary sodium excretion (along with a weak anion) 
while chloride excretion is maintained, as shown by the increased urinary sodium–
chloride ratios. The intravenous and enteral salt intake of patients was unchanged 
during the observation period. Thus, the renal effect of acetazolamide results in a 
relative increase in serum chloride. Because sodium and chloride are the most 
abundant and therefore the most important strong ions, an increase in chloride 
relative to sodium will have a significant lowering effect on serum SIDapp. Stewart 
proposed that H+ and therefore pH cannot change unless one or more of the three 
independent variables (PaCO2, weak acids, and SIDapp) change. Our study 
demonstrates that the acetazolamide-induced effects on pH are solely mediated 
by a decrease in serum SIDapp through renal excretion of sodium without chloride. 
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Although the Stewart approach has proved to be valuable in critically ill acidotic 
patients12-14, this paper represents the first report using the Stewart approach 
during metabolic alkalosis.
Our study confirms previous reports in patients with metabolic alkalosis that, 
despite corrected fluid and electrolyte abnormalities, a single dose of acetazolamide 
is an effective and safe form of therapy, with a quick onset and long duration of 
action5,15. Our findings suggest that the duration of the pharmacologic effect of a 
single administration of 500 mg acetazolamide exceeds its serum half-life (6–8 
hours). This long effect is reflected by the 24-hour duration of altered urinary sodium 
and chloride excretion. Furthermore, after normalization of serum pH at 24 hours, 
this correction was sustained although urinary electrolyte excretion and pH returned 
to pre-administration values. Apparently, once the serum SIDapp is corrected by 
acetazolamide because of the increased sodium excretion without a strong anion, 
this new equilibrium is maintained. The Stewart approach does not help us to 
explain the long-lasting effects of acetazolamide, and it is unclear how the new 
equilibrium is maintained after correction of the SIDapp and what the regulating 
mechanism is that induces the permanent hyperchloraemia. The pharmacokinetics 
of acetazolamide in tissue (not plasma) may explain this observation. Another 
explanation could be that the alkalizing factors that were originally present in our 
patients are corrected during the course of the observation period. Although clinical 
suspicion of a hypovolaemic state was an exclusion criterion in our study, one of the 
alkalizing factors could very well be some degree of volume contraction induced by 
the administration of diuretics. Whatever the cause, it is highly unlikely that the 
presence of some degree of hypovolaemia in our patients would influence our 
conclusions regarding the effects – as determined using the Stewart approach – of 
acetazolamide on metabolic alkalosis.
The SIG – indicative of the presence of unmeasured anions, which are often present 
in metabolic acidosis, particularly in patients with renal failure14 – was not found to 
be elevated in our study, as was expected. Furthermore, administration of aceta -
zolamide had no influence on the SIG.
Conclusion
Our study is the first to report the mechanism by which acetazolamide-induced 
correction of metabolic alkalosis in critically ill patients is mediated. Applying the 
quantitative biophysical principles of acid–base analysis described by Stewart, the
acetazolamide-induced effects on serum pH are completely accounted for by an 
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increased renal excretion of sodium without chloride, resulting in an increase in 
serum chloride and a decrease in serum SIDapp.
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Abstract
 
Introduction The physico-chemical approach to acid-base disorders has gained 
interest in critical care literature because of its superior performance in diagnosing 
complex acid base disorders. However, for critically ill patients with apparently 
normal acid base state according to conventional criteria, normal values of the 
Stewart parameters are currently unknown. This study aimed to describe values of 
the Stewart parameters in intensive care (ICU) patients without evidence of an acid 
base disorder and to identify possible subclinical abnormalities.
Methods A prospective, observational study was performed in three Dutch multi-
disciplinary intensive care departments. We included 312 consecutive ICU patients 
with normal pH (7.35≤ pH≤7.45) on day 3-5. In every patient three consecutive 
arterial blood samples were collected: at admission, at the day normal pH was 
reached and at ICU discharge. An apparently normal acid base state was defined 
as normal pH, -2<BE<2 and 35<PaCO2<45 mmHg. Apparent (SIDapp), effective 
strong ion difference (SIDeff) and strong ion gap (SIG) were calculated. Multivariate 
linear regression analysis was performed to analyze factors potentially associated 
with levels of SIDapp and SIG during normal pH. Covariates potentially relevant to 
the changes in acid-base state were obtained.
Results 137 patients were identified with an apparently normal acid base state. In 
this group, SIDapp values were 36.6±3.6 mEq/l, resulting from hyperchloremia 
(109±4.6 mEq/l), SIDeff values were 33.5±2.3 mEq/l, resulting from hypoalbumin-
emia (24.0±6.2 g/l) and SIG values were 3.1±3.1 mEq/l. During admission, BE 
increased secondary to a decrease in SIG levels and, subsequently, an increase in 
SIDapp levels. Hypoalbuminemia was present throughout the study. levels of SIDapp 
during normal pH were associated with positive ion load, chloride load and 
admission SIDapp (multivariate r2=0.40, P<0.001). levels of SIG during normal pH 
were associated with kidney function, sepsis and SIG levels at ICU admission 
(multivariate r2=0.28, P<0.001).
Conclusions ICU patients with an apparently normal acid base state according 
to traditional criteria have an underlying mixed metabolic acid base disorder 
characterized by acidifying effects of a low SIDapp (due to hyperchloremia) and high 
SIG (both acidifying effects) and the alkalising effect of a low level of the weak acid 
albumin. 
93
STEWART ANAlYSIS OF APPARENT NORMAl ACID BASE STATE IN THE CRITICAllY Ill
6
Introduction
Acid base disorders, predominantly metabolic acidosis, are common in critically ill 
patients. Their impact on morbidity and mortality, depending on both severity and 
cause, is substantial1. The physico-chemical approach first described by Stewart2 
has gained interest in critical care literature because of its superior performance in 
diagnosing and quantifying complex acid base disorders in comparison with the 
conventional Henderson Hasselbalch approach3-6. The Stewart approach takes 
into account many of the electrochemical disturbances seen in critically ill patients 
that are not a part of the conventional approach. Essentially, the Stewart approach 
states that only three independent variables determine blood pH: the PaCO2, the net 
charge balance of all completely dissociated ions (apparent strong ion difference, 
SIDapp) and the total amount of weak acids, mainly albumin and phosphate. 
The importance of accurately identifying and quantifying all causal factors in acid 
base derangements in ICU patients is increasingly appreciated. For example, 
numerous studies using the Stewart approach published over the past 10 years 
have facilitated our insight in the etiology of metabolic acidosis in ICU patients 
1,4,7,8. However, in our view, two important issues remain unclear. 
While normal values of Stewart parameters of healthy subjects are often reported 
9-12, reference values are currently unknown for critically ill patients with normal pH, 
BE and PaCO2. Considering the high incidence of metabolic derangements in 
critically ill patients, normal values of healthy subjects probably do not apply. We 
hypothesize that in ICU patients with normal pH, coexisting metabolic derangements 
will often be present, but go unnoticed when applying the traditional approach. 
Second, so far, studies largely report only single (mostly admission) values of ICU 
patients and do not focus on changes in response to institution of therapy and 
resolution of illness13. Serial measurements from the time of admission to the 
resuscitation and recovery phases will contribute to a better insight in the 
mechanisms and kinetics of acid base derangements in the critically ill 8. Thus, they 
will better allow to determine the role of etiological factors like renal failure, fluid 
policy and presence of sepsis. 
The purpose of the current study was twofold. First, our objective was to describe 
Stewart parameters in critically ill patients without evidence of an acid base disorder 
according to the traditional approach and to determine the incidence of subclinical 
non-respiratory acid-base abnormalities in these patients. Second, we aimed to 
explore the kinetics of the Stewart parameters and to determine the influence of 
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several factors like renal function, fluid management and the presence of sepsis on 
the observed metabolic changes in acid-base balance.
Methods
Study population
This prospective observational study was performed in three multidisciplinary ICU’s 
in The Netherlands (Onze lieve Vrouwe Gasthuis in Amsterdam, Radboud 
University Nijmegen Medical Centre in Nijmegen and Jeroen Bosch Hospital in ‘s-
Hertogenbosch). We studied 312 consecutive critically ill patients with a normal pH 
on day 3, 4 or 5 following ICU admission, defined as 7.35 ≤ pH ≤ 7.45. Patients were 
excluded if they were discharged or died before day 3. Acute Physiology and 
Chronic Health Evaluation (APACHE II) data and Simplified Acute Physiology Score 
(SAPS II) data were collected for each patient. Furthermore, modified APACHE II 
scores and SAPS II scores were employed in which assessment of acid-base 
parameters was not included. Clinical data were collected from (electronical) 
patient charts. Electrolytes, diuretics and volumes and composition of intravenous 
fluids, administered 24 h before normal pH value, were registered, as we considered 
this timeframe to be primarily of influence on electrolyte values at the time of normal 
pH. Urine output was registered 12 h before normal pH value, as this was considered 
a relevant time frame influencing electrolyte values at the time of normal pH. To 
compare acid base variables of critically ill patients with apparent normal acid base 
state with normal subjects, data of a previously reported healthy control group were 
used (n=15)12 
The local medical ethical committee approved the study and waived the need for 
informed consent, since there was no interference with routine clinical care.
Measurements
In every patient we collected arterial blood samples at three consecutive moments: 
at ICU admission, at the day normal pH was reached (day 3,4 or 5) and at ICU 
discharge. If length of ICU stay exceeded seven days, the last blood sample was 
collected on day seven.
In the collected arterial blood samples, pH, partial pressures of oxygen and carbon 
dioxide (PaO2 and PaCO2), and plasma concentrations of ionized calcium and 
lactate were measured on a blood gas analyzer (Rapidlab; Bayer Diagnostics, 
Breda, The Netherlands). Plasma concentrations of sodium, potassium, and 
chloride were analyzed using an ion-selective electrode on an Aeroset (Abbott 
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Diagnostics, Hoofddorp, The Netherlands) or on a Roche/Hitachi Modular Analytics 
P800 chemistry analyzer (Roche Diagnostics Nederland BV, Almere, Nederland); 
and plasma concentrations of magnesium, creatinine, urea, phosphate, bilirubin 
and albumin were measured on an Aeroset.   All measurements were performed on 
arterial blood samples collected simultaneously at the three moments during 
admission mentioned above. 
Definitions
In this study, in the patients with normal pH on day 3-5, we defined a mixed acid 
base disorder according to the traditional approach as either abnormal PaCO2 
(<35 mmHg or > 45 mmHg) or abnormal BE (< -2 mmol/l or > 2 mmol/l)1,9,14 
combined with a normal pH. Patients were classified into three groups based on 
the presence or absence of a mixed acid base disorder at the time of normal pH 
using the traditional approach: an apparently  ‘normal acid base state group’ 
(-2<BE<2 and 35 mm Hg≤PaCO2≤45 mm Hg), a ‘metabolic acidosis group’ (BE < 
-2) and a ‘metabolic alkalosis group’ (BE>2). The latter two groups were not 
classified as respiratory alkalosis and acidosis respectively, as they also contained 
patients with normal PaCO2 values. Furthermore, these names are chosen for 
reasons of clarity, as the main focus of this study is metabolic abnormalities during 
normal pH. Patients with no apparent metabolic abnormalities (-2<BE<2) at the 
time of normal pH and an abnormal PaCO2 were classified as ‘other’ and, for the 
same reason, excluded for further analysis. Renal failure was defined according to 
the RIFlE criteria15 (injury or failure). Total infused cation load was defined as the 
net charge of all infused strong positively charged electrolytes (sodium, potassium, 
magnesium and calcium) 24h before normal pH. Total infused anion load was 
defined as the net charge of all infused chloride 24h before normal pH. Total infused 
intravenous volume load was defined as the sum of all intravenously administered 
fluids 24h before normal pH. 
Calculations
Bicarbonate was calculated using the Henderson–Hasselbalch equation 
(pH=6.1+log ([HCO3–]/0.0301 PaCO2) and the standard base excess (SBE) using 
the Siggaard–Andersen formulae. The apparent (SIDapp = [Na+]+[K+]+[Ca2+]+ 
[Mg2+]–[Cl–]–[lactate–]) and effective strong ion difference (SIDeff = (2.46 x 10-8 x 
PaCO2 /10-pH) + ([albumin] x 0.123 x (pH – 0.631)) + ([phosphate] x (0.309 x pH – 
0.469)) and strong ion gap (SIG= SIDapp - SIDeff) were subsequently calculated. All 
mentioned concentrations are expressed in mEq/l, except for the concentrations 
of albumin (g/l), phosphate (mmol/l) and PaCO2 (mmHg).
96
CHAPTER 6
Statistical analysis
Continuous variables were described by the mean ± standard deviation (SD), or 
the median and interquartile range (IQR) for variables with skewed distributions. 
Except for length of stay on the ICU, all variables had a normal distribution, allowing 
for parametric testing. Differences in patient and baseline acid base characteristics 
between the three groups were tested using χ2 tests or using analysis of variance 
(ANOVA) with post hoc Tukey HSD depending on its measure. Time-dependent 
changes were compared and analysed using repeated measure analysis of 
variance (RM-ANOVA). Acid base variables at the time of normal pH of the normal 
acid base state group were compared with a previously reported healthy control 
group12 using unpaired Student’s T-test. Differences in acid base variables and 
baseline characteristics between the three groups (normal acid base, BE<-2 and 
BE>2) were determined using analysis of variance (ANOVA) with post-hoc Tukey 
HSD. In order to analyze factors associated with levels of SIDapp and SIG at the time 
of normal pH, a multivariate linear regression analysis method enter was performed 
in all patients. Variables that, on theoretical grounds, could be associated with 
levels of SIDapp at the time of normal pH (infused cation load, infused anion load, 
infused intravenous volume load, use of diuretics and admission SIDapp levels) 
were included in the univariate analysis. likewise, variables that theoretically could 
be associated with levels of SIG at the time of normal pH (renal failure (RIFlE 
categories Injury and Failure), creatinine levels, use of continuous venovenous 
hemo(dia)filtration (CVVH(D)) 24 h hours before normal pH, citrate anticoagulation, 
presence of sepsis, and SIG levels during ICU admission) were included in the 
univariate analysis. Variables that were associated with a P-value <0.15 in an 
univariate simple linear regression analysis were included for the multivariate 
analysis. Statistical significance was defined as a P< 0.05 and two-sided tests of 
hypotheses were used throughout. All data were analyzed  using SPSS version 18.0 
(SPSS, Chicago, Il, USA).
Results
Patients
A total of 312 patients with a normal pH on day 3-5 following ICU admission were 
included in our study. Baseline clinical and acid base related data are presented 
in table 1. The patients were divided into the three pre-defined groups: 137 patients 
were classified as ‘normal acid base state’ (normal BE and PaCO2), 75 were 
classified as ‘metabolic acidosis’ (BE<-2) and 74 patients were classified as 
‘metabolic alkalosis’ (BE>2). Twenty-six patients with -2<BE<2 but abnormal 
PaCO2 were classified as ‘other’ and excluded for further analyses (figure 1). 
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Relevant baseline clinical data of these three groups are presented in table 2.
Modified APACHE II and SAPS II scores were significantly higher in the metabolic 
acidosis group compared to the normal acid base state and the metabolic alkalosis 
group (for APACHE II P<0.05 and P=0.03, respectively and for SAPS II scores 
P=0.003 and P=0.006, respectively). Diuretics were used significantly more in the 
metabolic alkalosis group compared to normal acid base state and metabolic 
acidosis group (P=0.02 and P=0.02, respectively). There was a significantly lower 
number of surgical patients in the metabolic alkalosis group compared to the 
normal acid base state group and metabolic acidosis group, P<0.001 and P=0.03, 
respectively). 
Stewart parameters in three groups with normal pH
Stewart parameters in critically ill patients with normal acid base state 
according to the traditional approach
Acid base parameters at the time of normal pH of the three groups are presented in 
table 3 and illustrated in figure 2. In the normal acid base state group, SIDapp values 
were 36.6±3.7 mEq/l, which is lower than SIDapp values previously reported12 in 15 
healthy subjects (41.4±3.7 mEq/l, P<0.001). These reduced SIDapp values resulted 
from hyperchloremia (chloride levels 109±4.6 mEq/l), considering the normal 
mean values of all other components of the SIDapp (data not shown). SIDeff values 
in the normal acid base state group (33.4±2.3 mEq/l) were lower compared to 
Figure 1   Flowchart of patient groups. BE base excess (in mmol/l) PaCO2 
arterial CO2 tension.
Critically ill patients with
normal pH on day 3, 4 or 5
(n=312)
Normal acid base state
(n=137)
-2<BE<2 and normal PaCO2
‘Metabolic acidosis’
(n=75)
BE<-2
‘Metabolic alkalosis’
(n=74)
BE>2
Excluded patients
(n=26)
-2<BE<2 and abnormal PaCO2
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Table 1   Baseline clinical and acid-base-related characteristics of ICU patients 
with normal pH on day 3, 4 or 5 of admission
Overall (n=312)
Age, years, mean ± SD 63.9 ± 14.3
Male gender, n (%) 210 (67.3%)
APACHE II score, mean ± SD 20.5 ± 7.9
SAPS II score, mean ± SD 46.2 ± 16.9
Mechanical ventilation during study, n (%) 275 (88.1%)
Mechanical ventilation at normal pH, n (%) 196 (62.8%)
lOS (days), median (IQR), extreme values 5 (4-12), 3-223
Mortality, n (%) 58 (18.6%)
Sepsis, n (%) 71 (22.8%)
Surgical patient, n (%) 123 (39.4%)
Admission diagnosis, n (%)
cardiovascular 54 (17.3%)
pulmonary 67 (21.5%)
abdominal 12 (3.8%)
neurological 27 (8.7%)
Surgery, elective 69 (22.1%)
Surgery, urgent 42 (13.5%)
Surgery, trauma 12 (3.8%)
other 29 (9.3%)
CVVH(D) 24 h before normal pH, n (%) 42 (13.5%)
Citrate anticoagulation, n (%) 30 (9.6%)
pH,  mean ± SD 7.34 ± 0.1
BE, mean ± SD -2.9 ± 5.49
PaCO2, mm Hg, mean ± SD 42 ± 12.6
Chloride, mean ± SD 107 ± 6
lactate, median (IQR), extreme values 1.7 (1.1-2.6), 0.4-18.8
Plasma creatinine, μmol/l, median (IQR), extreme values 93 (73-131), 23-796
APACHE II Acute Physiology and Chronic Health Evaluation II, SAPS II Simplified Acute Physiology 
Score CVVH(D) Continuous Venovenous Hemo (dia) filtration
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healthy subjects (40.0±3.8 mEq/l, P<0.001)12. These low SIDeff values resulted 
from hypoalbuminemia (albumin levels 24.0±6.2 g/l), considering the normal 
mean bicarbonate and phosphate levels in the normal acid base state group. 
lastly, SIG values in the normal acid base state group (3.1±3.2 mEq/l) were higher 
than levels reported in healthy subjects (1.4±1.8 mEq/l, P=0.04)12.
The etiology of mixed acid base disorders according to Stewart
SIDapp
Compared to the normal acid base state group, SIDapp levels in the metabolic 
acidosis group were significantly lower (P<0.001) (acidifying effect) and SIDapp 
levels in the metabolic alkalosis group were significantly higher (P<0.001) (alkalising 
effect). This difference in SIDapp levels between the groups was completely 
explained by the significant differences in chloride levels, as the other strong ions 
that constitute SIDapp were not different between groups (data not shown). 
Table 2   Base line clinical characteristics of three groups with normal pH at 
day 3,4 or 5 according to BE
Normal acid 
base state
(n=137)
BE < -2
(n= 75)
BE > 2
(n=74)
APACHE II score, mean ± SD 20.1 ± 7.6 22.8 ± 8.0a 19.4 ± 8.1b
APACHE II score  
adjusted for admission pH, mean± SD
19.3 ± 7.1 21.6 ± 7.8 18.5 ± 7.9 b
SAPS II score, mean ± SD 44.3 ± 15.7 52.4 ± 16.2a 43.9 ± 18.9b
Mortality, n (%) 29 (21.2%) 12 (16.2%) 15 (20.8%) 
Sepsis, n (%) 29 (21.2%) 22 (29.3%) 15 (20.3%)
Surgical patient, n (%) 67 ( 48.9%) 29 (38.7%) 16 (21.6%)a,b
Renal failure during normal pH 59 (43.1 %) 31 (41.3%) 24 (32.4%)
Diuretics 24h before normal pH, n (%) 42 (30.7%) 22 (28.2%) 37 (50.0%)a,b
CVVH(D) 24 h before normal pH, n (%) 24 (17.5%) 6 (8%) 9 (12.2%)
Citrate anticoagulation, n (%) 18 (13.1%) 3 (4%)a 6 (8.1%)
APACHE II Acute Physiology and Chronic Health Evaluation II, SAPS II Simplified Acute Physiology 
Score CVVH(D) Continuous Venovenous Hemo (dia) filtration a statistically significantly different 
(p<0.05) compared to normal BE; b statistically significantly different (p<0.05) compared to BE <-2. 
Exact p values are mentioned in Results section of the text. 
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SIDeff
Compared to the normal acid base state group, SIDeff levels in the metabolic 
acidosis group were also significantly lower (P<0.001) and SIDeff levels in the 
metabolic alkalosis group were significantly higher (P<0.001). This was mainly 
explained by the significant difference in bicarbonate levels, as the concentrations 
of the weak acids albumin were not significantly different and phosphate levels 
were only marginally different between groups. 
SIG
SIG levels were significantly lower (alkalising effect) in the metabolic alkalosis group 
compared to the metabolic acidosis group (P<0.001) and normal acid base group 
respectively (P=0.03). The SIG levels of the normal acid base group tended to be 
lower (P=0.057) compared to the metabolic acidosis group. 
PaCO2
In the metabolic acidosis group PaCO2 levels were significantly lower (alkalising 
effect) compared to the normal acid base state group and the metabolic alkalosis 
group (both P<0.001). Furthermore, PaCO2 levels were significantly higher in the 
Table 3   Acid base parameters of three groups during normal pH at day 3,4  
or 5 according to BE
Normal acid 
base state
(n=137)
BE < -2
(n= 75)
BE > 2
(n=74)
pH, mean ± SD 7.41 ± 0.03 7.39 ± 0.03a 7.42 ± 0.03b
PaCO2 (mmHg),  mean ± SD 39 ± 3 34 ± 4a 47 ± 6a,b
BE, mean ± SD 0.1 ± 1.1 -4.1 ± 1.5a 4.9 ± 2.2a,b
SIDapp (mEq/l),  mean ± SD 36.6 ± 3.7 33.2 ± 3.5a 41.2 ± 3.8a,b
Sodium (mmol/l), mean ± SD 139 ± 4.2 140 ± 6.1 140 ±4.2
Chloride (mmol/l), mean ± SD 109 ± 4.6 113 ± 6.0a 106 ± 4.7a,b
lactate (mmol/l), median (IQR) 1.5 (1.2-1.9) 1.6 (1.2-2.0) 1.3 (1.0-1.7)
SIDeff(mEq/l),  mean ± SD 33.4 ± 2.3  28.8 ± 2.7a 39.3 ± 3.3a,b
Albumin (g/l), mean ± SD 24.0 ± 6.2 23.0 ± 5.6 24.8 ± 6.5
Phosphate (mmol/l), mean ± SD 1.0 ± 0.3 1.1 ± 0.4 1.0 ± 0.3b
SIG (mEq/l),  mean ± SD 3.1 ± 3.2 4.3 ± 3.5 1.8 ± 2.9a,b
a statistically significantly different (p<0.05) compared to normal BE; b statistically significantly 
different (p<0.05) compared to BE <-2
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metabolic alkalosis group (acidifying effect) compared to the normal acid base 
state group (P<0.001). 
Kinetics of Stewart parameters
The kinetics of Stewart parameters during the first week of admission prior and 
following normalisation of pH on three consecutive moments are presented in table 4.
Prior to normalisation of pH
Regardless of acid base state during ICU admission, the same trend was noticed 
in all three groups. A significant rise in pH (mainly acidosis at admission with 
subsequent normalization of pH) is, apart from a slight decrease in PaCO2 levels, 
primarily associated with an increase in BE. In the normal acid base state group 
and metabolic alkalosis group this increase in BE (P=0.0001 and P=0.0001, 
respectively) is accompanied by a significant decrease in SIG levels (P=0.0001 
and P=0.001) and a marginal, but significant decrease in phosphate levels 
(P=0.008 and P=0.003). In addition, a marginal decrease in albumin levels was 
observed in the metabolic alkalosis group (P=0.01). (Table 4)
Figure 2   Acid base parameters at the time of normal pH, all expressed in mEq/l, 
in the ‘normal acid base state’ group (normal BE and PaCO2, n=137), 
‘metabolic acidosis’ group  (BE<-2, n=75) ‘metabolic alkalosis’ group 
(BE>2, n=74). * statistically significantly different (P<0.05) compared 
to normal BE.
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Table 4   Kinetics of acid  base parameters during first week of ICU admission 
of three groups with normal pH at day 3,4 or 5 (t=2) according to BE
t=1
(day 1)
t=2  
(day 3,4 or 5)
t=3
discharge/
day 7
Normal acid base state (n=137)
pH, mean ± SD 7.35 ± 0.09 7.41 ± 0.03a 7.43 ± 0.05a,b
PaCO2 (mmHg),  mean ± SD 40 ± 9 39 ± 3 41 ± 6b
BE, mean ± SD -3.4 ± 4.6 0.1 ± 1.1a 2.3 ± 3.0a,b
SIDapp (mEq/l), mean ± SD 36 .1 ± 5.2 36.6 ± 3.7 39.3 ± 4.5a,b
SIDeff (mEq/l), mean ± SD 30.7 ± 4.6 33.4 ± 2.3a 35.8 ± 3.5a,b
Albumin (g/l), mean ± SD 24.2 ± 6.9 24.0 ± 6.2 24.1 ± 6.0
Phosphate (mmol/l), mean ± SD 1.2 ± 0.5 1.0 ± 0.3a 1.1 ± 0.3b
SIG (mEq/l), mean ± SD 5.3 ± 4.7 3.1 ± 3.2a 3.4 ± 3.6a
BE <-2 (n=75)
pH, mean ± SD 7.32 ± 0.10 7.39 ± 0.03a 7.42 ± 0.06a,b
PaCO2 (mmHg),  mean ± SD 37 ± 10 34 ± 4a 37 ± 7b
BE, mean ± SD  -6.0 ± 4.3 -4.1 ± 1.5a -0.6 ± 4.3a,b
SIDapp (mEq/l), mean ± SD 33.8± 6.3 33.2 ± 3.5 36.3 ± 4.8a,b
SIDeff (mEq/l), mean ± SD 27.9 ± 4.9 28.8 ± 2.7 32.5 ± 4.9a,b
Albumin (g/l), mean ± SD 24.5 ± 7.9 23.0 ± 5.7 23.2 ± 5.7
Phosphate (mmol/l), mean ± SD 1.3 ± 0.6 1.1 ± 0.4 1.1 ± 0.4
SIG (mEq/l), mean ± SD 6.0 ± 5.5 4.3 ± 3.5a 4.0 ± 3.3a
BE >2 (n=74)
pH, mean ± SD 7.35 ± 0.11 7.42 ± 0.03a 7.41 ± 0.06a
PaCO2 (mmHg),  mean ± SD 50 ± 17 47 ± 6 49 ± 10
BE, mean ± SD 0.6 ± 6.6 4.9 ± 2.2a 4.8 ± 3.3a
SIDapp (mEq/l), mean ± SD 40.3 ± 6.2 41.2 ± 3.8 41.0 ± 5.2
SIDeff (mEq/l), mean ± SD 36.3 ± 7.4 39.3 ± 3.3a 39.6 ± 4.6a
Albumin (g/l), mean ± SD 26.3 ± 7.9 24.8 ± 6.5a 25.0 ± 6.4
Phosphate (mmol/l), mean ± SD 1.2 ± 0.5 1.0 ± 0.3a 1.1 ± 0.3b
SIG (mEq/l), mean ± SD 4.2 ± 5.0 1.8 ± 2.9a 1.5 ± 3.0a
a statistically significant change (p<0.05) compared to t=1; b statistically significant change p<0.05) 
compared to t=2
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Admission SIDapp values in the metabolic acidosis group were significantly lower 
compared to the metabolic alkalosis group (P<0.0001), and borderline lower 
compared to the normal acid base state group (P=0.056). Admission SIDeff values 
showed similar trends (table 4).
Following normalisation of pH
In the normal acid base state and metabolic acidosis group, pH increased further 
following normalisation, associated with a significant increase in BE, as the slightly 
increasing PaCO2 levels account for a acidifying effect. This further increase in BE 
was accompanied by an increase in SIDapp levels (responsible for an alkalising 
effect). This increase in SIDapp levels was almost completely caused by a significant 
decrease in serum chloride levels (from 109±4.6 mmol/l to 107±3.9 mmol/l, 
P<0.001 in the normal acid base state group and from 114±6.1 mmol/l to 111±6.4 
mmol/l, P=0.003 in the metabolic acidosis group), as well as a slight decrease in 
lactate levels (from 1.6±0.8 mmol/l to 1.5±0.8 mmol/l, P=0.045 in the normal acid 
base state group and from 1.6±0.7 mmol/l to 1.5±0.6 mmol/l, P=0.01 in the 
metabolic acidosis group) and an increase in calcium levels (from 1.1±0.1mmol/l 
to 1.2±0.1 mmol/l, P=0.008 in the normal acid base state group and from 
1.1±0.2mmol/l to 1.2±0.1 mmol/l, P=0.001 in the metabolic acidosis group). 
levels of the weak acid albumin did not significantly change over time and levels of 
phosphate only increased marginally in the normal acid base state group. 
Accordingly, the observed increase in SIDeff levels in the normal acid base state 
group and metabolic acidosis group is almost completely explained by an increase 
in bicarbonate levels. In the metabolic alkalosis group, no significant changes 
occurred in the acid base parameters following normalisation of pH, except for a 
marginal increase in phosphate levels (table 4).
Covariates that modulate acid-base balance
Factors associated with SIDapp
Total infused cation load, total infused chloride load, total infused volume load, 
diuretic use and admission SIDapp levels were univariately associated (P<0.15) with 
SIDapp levels during normal pH. Subsequently, multivariate regression analysis 
showed that SIDapp during normal pH remained significantly and independently 
associated with cation load, chloride load and admission SIDapp. The adjusted r2 of 
the model was 0.40 (standard error of estimate 3.51); P<0.001. Regression coefficients 
are outlined in table 5. 
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Factors associated with SIG
Renal failure during normal pH, creatinine levels during normal pH, use of CVVH(D) 
24 hrs before normal pH, use of citrate anti-coagulation, SIG levels during admission 
and sepsis were univariately associated (P<0.15) with SIG during normal pH. After 
multivariate analysis, SIG during normal pH remained significantly and independently 
associated with creatinine during normal pH, sepsis and SIG levels at ICU 
admission. The adjusted r2 of the model is 0.28 (standard error of estimate 2.78; 
P<0.001). Regression coefficients are outlined in table 6. 
Table 5   Uni- and multivariate analysis of factors associated with SIDapp levels 
at normal pH
Univariate analysis Multivariate analysis
B 95% CI P value B 95%CI P value
Cation load 0.251 0.135- 0.345 <0.001 0.232 0.142-0.321 <0.001
Chloride load -0.006 -0.008- -0.004 <0.001 -0.005 -0.008- -0.002  0.001
IV volume -0.001 -0.001- -0.001 <0.001
Diuretic use 2.081 1.038- 3.123 <0.001
Admission SIDapp 0.414 0.342-0.485 <0.001 0.344 0.273-0.415 <0.001
IV intravenous
Table 6   Uni- and multivariate analysis of factors associated with SIG levels at 
normal pH
Univariate analysis Multivariate analysis
B 95% CI P value B 95% CI P value
Renal failure 1.248 0.500- 1.996 0.001
Creatinine 0.014 0.01- 0.018 <0.001 0.009 0.005- 0.014 <0.001
CVVH(D) 1.628 0.567- 2.689 0.003
Citrate 
anticoagulation
1.727 0.496- 2.957 0.006
Sepsis 2.417 1.568- 3.266 <0.001 1.391 0.584-2.198 0.001
Admission SIG 0.28 0.210-0.350 <0.001 0.210 0.138-0.281 <0.001
CVVH(D) continuous venovenous hemo(dia)filtration
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Discussion
The main findings of this study are threefold. First, we described values of Stewart 
parameters in critically ill patients without evidence of acid base abnormalities 
according to the traditional criteria and determined the incidence of subclinical 
acid-base abnormalities. Second, we explored the kinetics of the acid base 
parameters during the first week of ICU admission, using the Stewart approach. 
Following ICU admission, pH rises which is largely a result of metabolic changes, 
indicated by an increase in BE. This increase in BE seems to be almost completely 
explained by a decrease in SIG levels prior to normalisation of pH and, subsequently, 
by an increase in SIDapp levels following normalisation of pH. Third, we identified 
three factors that were independently related to SIDapp levels during normal pH, 
namely SIDapp at ICU admission, total infused cation load and chloride load 24 
hours before normal pH. Furthermore, creatinine levels, presence of sepsis and 
SIG levels at ICU admission were related to SIG levels during normal pH.  
Stewart parameters in three groups with normal pH
Approximately 50% of our studied ICU patients with normal pH had an underlying 
mixed acid base disorder according to criteria traditionally used (either abnormal 
BE and/or PaCO2). However, even critically ill patients with an apparently normal 
acid base state according to the conventional criteria (pH, BE and PaCO2 within the 
reference range) have an underlying mixed acid base disorder that emerged using 
the quantitative physico-chemical approach. Compared with data reported from 
normal subjects 9-12, this mixed metabolic disorder is characterized by a combination 
of a low SIDapp (due to hyperchloremia), high SIG (both acidifying effects) and a low 
level of the weak acid albumin (alkalising effect). Apparently, traditional methods of 
assessing acid base status fail to diagnose complicated acid base disorders in 
critically ill patients, especially in case of hypoalbuminemia or high levels of strong 
anions, both common findings in this patient category. Although other authors 
mentioned this point previously12,16, as far as we know our study is the first to report 
a detailed quantitative analysis of a large group of critically ill patients with an 
apparently normal acid base status. Moreover, considering this large group of 
studied patients and recognizing that the critically ill patient with normal pH, BE and 
PaCO2 is metabolically different from a healthy person, does not prove, but may 
suggest that low SIDapp, high SIG and low albumin levels could be regarded as an 
adaptive phenomenon during critical illness. Nevertheless, this seems unlikely, as 
hypoalbuminemia (an alkalising factor) is considered to be an inevitable event in 
critically illness and not a regulated variable for acid base purposes. Accordingly, 
increased SIG levels are probably a result of organ dysfuncion and the underlying 
disease or its therapy (see later). However, the low SIDapp values may (at least 
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partially) reflect an appropriate renal response. Recently, several chloride carriers 
in the proximal tubules and distal nephron are identified that underline the role of 
chloride in renal acid-base regulation17. In this view, our results illustrate that in case 
of hypoalbuminemia, SID may be reset to a lower level in order to maintain a normal 
pH, as previously suggested12,18. 
Kinetics of Stewart parameters
Exploring the dynamics of acid base parameters during the first week of ICU 
admission, we found that levels of SIDapp return to levels almost comparable with 
healthy subjects, irrespective of whether patients had a mixed acid base disorder 
(according to traditional criteria) or not. Additionally, following normalisation of pH, 
SIG levels remained higher than levels reported for healthy subjects and hypo-
albuminemia persisted. This is in accordance with the recent study of Gunnerson et 
al, who reported the data of 15 stable ICU patients just before ICU discharge12. 
Apparently, in time, the main contributors to a change in acid base status in critically 
ill patients are, first, a decrease (but not complete normalisation) of SIG levels and, 
second, an increase (but not normalisation) of SIDapp levels. The contribution of the 
respiratory component appears to be only minor. As 63% of our patients were 
mechanically ventilated during normal pH, minute ventilation may, at least partially, 
be influenced by sedation and ventilation strategy.  The decrease in SIG levels prior 
to normalization of pH may likely be related to (partial) resolution of disease. High 
(pre-resuscitation) SIG levels at ICU admission are known to be related to the 
presence of sepsis, renal and hepatic dysfunction and are probably a marker of 
tissue hypoperfusion as well19-22. Some studies23-26 found a clear association 
between high SIG levels and mortality while another did not27. Therefore, the 
prognostic significance of high SIG levels during admission remains to be 
determined, but is probably more relevant when pre-resuscitation values are 
measured4,25,27. Possibly, in our study, when pH normalized after 3 to 5 days 
following ICU admission, SIG levels decreased as a result of (partial) recovery of 
organ function or for example institution of renal replacement therapy. The increase 
of SIDapp levels following normalization of pH in our study is almost completely 
explained by a decrease in chloride levels and might be related to further recovery 
of organ function. For example, the ability to excrete excess chloride in urine is 
directly related to renal function28. Furthermore, large amounts of intravenous 
unbalanced fluids are unlikely to be administered in a more stable phase of disease. 
Unfortunately, we did not collect data of fluid in- and output following normalization 
of pH to support this possibility. 
Covariates that modulate acid-base balance
As mentioned, we also focused on the influence of endogenous and exogenous 
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factors on the observed SIDapp and SIG levels during normal pH. Using multivariate 
linear regression analysis, we showed that the low SIDapp levels during normal pH 
were independently related to admission SIDapp levels, low cation loading and high 
chloride loading 24 hours before normal pH. Surprisingly, dilution (expressed as 
electrolyte free IV volume load) and diuretic use, both significantly related to low 
SIDapp levels in the univariate analysis, did not maintain statistical significance 
following multivariate analysis. Admission SIDapp levels, cation and chloride load 
(the latter having opposite effects) together account for only 40 percent of the 
observed SIDapp levels during normal pH. Apparently, other factors not accounted 
for in the analysis also play a role. Potential candidates are infused volume and 
electrolytes in the first two days of admission, anion flux from the intracellular and 
interstitial (changing Gibbs-Donnan equilibrium) compartment and, as mentioned 
above, presumably increased renal chloride retention as an adaptive response to 
the alkalising factor hypoalbuminemia. SIG levels in the patients with normal pH 
were independently related to creatinine levels, the presence of sepsis and SIG 
levels during admission. Together, these three factors account for 28 percent of the 
observed SIG levels during normal pH. So, again, other factors not accounted for 
in our analysis apparently play an important role. Although SIG levels during normal 
pH decreased compared to their admission values, they are still elevated compared 
to healthy subjects. Persistent occult tissue hypoperfusion or hepatic dysfunction 
may account for this. Also, the administration of acetoaminophen, especially in 
combination with antibiotics like flucloxacillin and/or depleted glutathion reserves 
can cause high levels of pyroglutamic acid29. Although almost all patients were 
treated with 4x1 gram acetoaminophen, we did not register its use in individual 
patients and therefore could not relate it to their SIG levels. In 2 previous studies on 
the nature of high SIG levels in metabolic acidosis in ICU patients, pyroglutamic 
acid was not a significant contributing factor22,30. Gelatins, which are comprised of 
negatively charged polypeptides, are a known source of ‘unmeasured’ anions31, 
but were not used in our study. In general, the nature of the increased SIG in ICU 
patients is currently largely unknown and likely multifactorial22. 
Conclusions
This is the first study decribing Stewart acid base parameters in an ICU population 
with no apparent acid base abnormalities. We demonstrated that our studied ICU 
patients with normal pH, PaCO2 and BE had an underlying mixed acid base 
disorder. Furthermore, our results suggest that during recovery of critical illness, 
the alkalizing effect of hypoalbuminemia is nullified by a low SIDapp (mainly due to 
hyperchloremia) and high SIG levels. Whether this should be interpreted as an 
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adaptive response or as a complex mixed acid base disorder remains speculative. 
Additionally, we showed that high chloride load, low cation load and low admission 
SIDapp were independently related to these low SIDapp levels. Creatinine levels, the 
presence of sepsis at admission and admission SIG levels were independently 
related to high SIG levels during normal pH.
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In this chapter, we summarize and discuss the main findings of this thesis in the 
light of recent studies performed during and after the conduct of our own research. 
We focused on metabolic derangements, since these can be easily overlooked by 
the traditional Henderson-Hasselbalch approach and potentially have a significant 
impact on morbidity and outcome. 
Chapter 1 is a short introduction to acid base disorders in the ICU patient in general 
and, more specifically, the Stewart approach. We conclude that, although the 
traditional (Henderson Hasselbalch) approach provides an accurate quantification 
of a metabolic acid-base derangement, the Stewart approach potentially provides 
an advanced insight in the mechanisms that cause it. However, due to its complexity, 
its clinical applicability is limited.
Part one: Etiology of metabolic acidosis in the ICU
In the first part of the thesis, we investigated the characteristics of metabolic acidosis 
in critically ill patients, the nature of unidentified strong anions and the influence of 
renal handling of strong ions. 
The Stewart approach versus the traditional approach
In chapter 2, we compared a quantitative physico-chemical analysis of metabolic 
acidosis of 50 ICU patients with the traditional Henderson-Hasselbalch approach. 
We demonstrated that metabolic acidosis in ICU patients is a complex, multifactorial 
disorder with a high incidence of hyperchloremia, hyperlactatemia and strong ion 
gap acidosis. In approximately half of the cases three causes of acidosis were 
found simultaneously. 
We showed that the traditional approach combined with an (uncorrected) anion 
gap lacks diagnostic sensitivity for the detection of hyperlactatemia, which 
obviously should not be missed. This was previously also shown in a selected 
group of trauma patients1. Meanwhile, following our study, this finding was 
confirmed several times in different cohorts of general ICU patients2-4. We showed 
that an albumin-corrected anion gap performs better with respect to detection of 
hyperlactatemia. Moreover, we found an excellent relationship between the 
albumin- and lactate corrected anion gap (AGcorr) and the SIG in patients with a 
metabolic acidosis admitted to the ICU. This means that the strong anions that 
contribute to acidosis, other than lactate, can be easily quantified at the bedside, 
avoiding the complex calculation of the SIG. More recently, the strong association 
between the albumin- and lactate corrected anion gap (AGcorr) and the SIG has 
also been confirmed in different subsets of ICU patients3-7. Potentially, this has 
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important clinical implications. Clinicians caring for the critically ill should be 
properly informed about the presence of markers of shock or specific metabolic 
derangements, which may have impact on the ability to identify the underlying 
disease and therapeutic options. Furthermore, they should be able to identify 
factors that may contribute to morbidity and outcome. The presence of strong 
anions, that contribute to the acidosis and may have an impact on outcome, can be 
easily and reliably detected by calculation of an AGcorr. Our study suggests that a 
SIG level of >2 mEq/l can be considered abnormal in critically ill patients, as 
normal AGcorr levels (<12 mEq/l) correlated with SIG levels < 2 mEq/l.
More and more recent studies underline the importance of the Stewart approach, 
also in patients with an apparently normal acid base state. In patients with pH and 
base excess values within the normal range, there might well be a significant 
underlying acidosis due to lactate or other strong anions, which is masked by a 
concomitant metabolic alkalosis secondary to increased SIDapp or hypoalbuminema8. 
In this way, a clinically relevant hyperlactatemia can be missed when the clinician 
confines to the traditional acid-base analysis: combined abnormalities resulting in 
normal pH and base excess are not necessarily equal to normal. Therefore, recent 
studies on this subject suggest measuring lactate levels in all admissions2, irrespective 
of pH and base excess.
In conclusion, at present, considering the evidence, it is generally accepted that the 
minimum diagnostic work-up that should be done in an ICU patient with a metabolic 
acidosis is calculation of an albumin corrected anion gap. In addition, measuring 
lactate levels is reasonable in all admissions.
 
The nature of the strong ion gap
We investigated the nature of the unknown components that constitute the strong 
ion gap (SIG) in chapter 3, because its identity was unclear and a significant 
association with poor outcome was reported repeatedly in different subsets of ICU 
patients5,9-12, even in a subgroup of trauma patients with normal admission lactate6. 
To this end, we studied 31 consecutive critically ill patients with metabolic acidosis 
and compared two groups: patients with SIG of <2 mEq/l and patients with SIG of 
>5 mEq/l. We performed amino acid, uric acid and organic acid analysis by 
various chromatography/mass spectrometry techniques and Hydrogen-1 Nuclear 
Magnetic Resonance Spectroscopy. We demonstrated that only 7.9% of the 
difference in SIG between the low (≤2 mEq/l) and high (≥5 mEq/l) SIG groups 
could be explained by the presence of high concentrations of amino acids, uric 
acid, and organic acids. As a single compound, uric acid was responsible for 
approximately one quarter of the identified SIG. The role of Krebs cycle anions, 
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suggested earlier in literature by Forni et al13, could not be confirmed by our study. 
Only succinic acid was significantly elevated in the high SIG group, but it accounted 
for only 0.07% of the increased SIG. Furthermore, concentrations of isocitrate and 
citrate obtained by gas chromatography were not relevantly elevated in the high 
SIG group and all intermediates of the citric acid cycle quantified with 1H-NMR 
spectroscopy, including acetic acid, corresponded to the published reference 
ranges. Accelerated amino acid catabolism would imply distinct patterns of altered 
amino acid concentrations, which also was not supported by the results of our 
study. The differences between our results and those of Forni et al. could be 
explained by the limited size and heterogeneity of the patient groups, analytic 
differences and differences in exogenously administered medications and fluids.
In spite of our efforts, so far, the source and identity of the anions representing an 
elevated SIG remains largely speculative. A starting point for designing future studies 
identifying the nature of the SIG may be the clear association of high SIG values with 
several specific disease states and/or its treatment. For example, unidentified drug 
additives and drug metabolites still remain possible candidates, considering the 
association of an increased SIG with hepatic dysfunction14. In our study, we detected 
a peak in the organic acid profile, co-eluting with the Krebs cycle intermediate fumaric 
acid. Using mass-spectrometric analysis, this peak could be attributed to an antibiotic 
or antibiotic derived metabolite. Second, the clear association of an elevated SIG with 
renal failure still suggests that uremic compounds, at least partially, play a role. Third, 
the high incidence of sepsis in the high SIG group suggests a specific role for this 
type of shock (or its treatment) in producing unknown negatively charged compounds. 
A recent study of thirty septic shock patients with metabolic acidosis confirmed the 
frequent presence of increased levels of unmeasured anions in this specific patient 
group. Seventy percent of septic shock patients showed an increased SIG, even 
when applying a relatively high cut-off value of 8 mEq/l7. Interestingly, in this study 
23% of the patients with increased levels of unmeasured anions showed normal base 
excess levels because of the simultaneous presence of hypochloremia, representing 
an alkalizing effect. In spite of this clear association between sepsis and high levels 
of unmeasured anions, the source of these negatively charged compounds in sepsis 
is still unknown and could be related to both cellular hypoxia and specific inflammatory 
products. Furthermore, the association between sepsis and the presence of high 
levels of unmeasured anions may be confounded by concurrent renal failure in septic 
patients, although there was no difference in the incidence of renal failure between 
septic and non-septic subjects in our study. Future studies should focus on this 
aspect. 
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The association between increased SIG and unfavorable outcome, independent of 
lactate, is again confirmed following our report in a retrospective study of cardiac 
arrest patients treated with mild therapeutic hypothermia15 and even in a general 
ICU population with normal base excess16. Therefore, an increased SIG is likely to 
be a surrogate marker of tissue damage.
However, in light of all this, it is important to mention that controversy remains in the 
literature regarding normal values for SIG in critically ill patients, and thus, the 
definition of an abnormal SIG with associated adverse outcome.
The role of renal (dys)function
According to the quantitative physico-chemical approach of Stewart, the only 
possible mechanism for the kidneys to correct acidosis, whatever its cause, is 
increasing the serum strong ion difference by excreting chloride together with 
NH4+17. This is reflected by a decreased urinary strong ion difference. Theoretically, 
decreased renal function could result in an impaired ability to correct pH. This 
concept was previously clinically studied in 12 patients with primary distal RTA 
(renal tubular acidosis), a genetic disorder in which renal chloride excretion is 
impaired18. Compared with healthy controls, these patients showed a significant 
increase in plasma chloride after an intravenous saline bolus, which correlated with 
decreased fractional chloride excretion in the urine and a decrease in plasma pH. 
However, until now, this concept was not studied in critically ill patients.
Therefore, in chapter 4, we examined the renal defense mechanism against 
acidosis by measuring urinary strong ion excretion in 65 consecutive critically ill 
patients suffering from metabolic acidosis. Higher plasma creatinine concentrations 
were significantly associated with greater urinary simplified SID values (urinary 
[Na+]-[Cl-]), and subsequently, these were significantly related to lower blood pH 
levels. These findings suggest that less urinary strong anion excretion during renal 
failure represents a determinant of the metabolic acidosis in these patients. This 
study further illustrated the central role the kidneys play in acid base regulation. As 
urinary chloride excretion was hampered in patients with decreased renal function 
in our study, we concluded that these patients fail to compensate for their acidotic 
state, resulting in a more pronounced and sustained acidosis in patients with 
impaired renal function. 
Our study was the first to examine urinary strong ion excretion and acid-base status 
in relation to renal function in critically ill patients and illustrated the importance of 
renal chloride excretion to correct for acidosis. Concurrently with our study, a 
prospective observational study was reported in which 98 ICU patients with 
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metabolic acidosis were compared with healthy volunteers19. In accordance with 
our results, these authors found that patients with higher urinary SID (qualified as 
inappropriate renal compensation) had more severe acidosis. The relation between 
urinary SID and renal function was not subject of this study. Also, recently, an 
experimental study investigating the effects of several infused crystalloids with a 
different SIDapp on acid-base status of healthy pigs with normal kidney function was 
published 20. In this study, the renal response to the infused solutions was evaluated 
by measuring urine output and urinary anion gap. The authors found that variations 
in plasma SIDapp were significantly correlated with variations in the urinary anion 
gap. Importantly, these changes in urinary anion gap were only related to both 
urinary [Na+] and [Cl-]. In contrast, urinary [K+] changes were only associated with 
potassium load during infusions and not with urinary anion gap changes. Again, 
this study confirms the important role of renal chloride excretion (relative to sodium 
excretion) in acid base regulation. Furthermore, recently, several chloride carriers in 
the proximal tubules and distal nephron are identified that illustrate the role of 
chloride in renal acid-base regulation21-23.
Apart from exploring the relevance of renal anion excretion in metabolic acidosis, 
we also confirmed that increased levels of SIG and the weak acid phosphate largely 
explained the acidosis of patients with renal failure. This was previously reported in 
a study comparing acidotic ICU patients with acute renal failure with ICU patients 
without renal dysfunction24. The greater SIG values associated with declined renal 
function are probably explained by a decreased renal clearance of these anions. 
The importance of renal chloride excretion to correct for acidosis has implications 
for clinical practice. Clinicians should be aware that, particularly in renal failure 
patients, massive chloride loading with unbalanced fluids like classic crystalloids 
and colloids is likely to induce iatrogenic hyperchloremic acidosis25. This is 
probably not just an irrelevant metabolic phenomenon that can be ignored, as it 
might contribute to alterations in inflammatory response and organ dysfunction26-
29. Moreover, a recent prospective study of severe sepsis and septic shock patients 
reports decreased admission inorganic ion difference (attributable to hyper-
chloremia) to be independently associated with mortality30. Although up to now 
human clinical studies are inconclusive with respect to effects on outcome, it 
appears reasonable that hyperchloremic acidosis should be avoided whenever 
possible. Therefore, balanced fluids, which contain less chloride, are preferable, 
especially in renal failure patients whenever substantial volume resuscitation is 
indicated. So far, few studies have focused on the clinical effects of implementing 
a ‘balanced’ fluid strategy in critically ill patients. In a recent prospective, open label 
study of the effects of rigorously restricting chloride-rich fluids in a tertiary ICU, the 
incidence of severe metabolic acidosis decreased from 9.1% to 6.1% (with a 
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decrease in incidence of hyperchloremia and hypernatriemia), but at the cost of an 
increased incidence of severe metabolic alkalosis (10.4% to 14.7%)31. So, apparently, 
just abandoning prescriptions of chloride-rich fluids in our intensive care unit is not 
the simple answer to the problem of iatrogenic acid base disorders. Probably, not 
only the volume but also the composition of IV fluids should be carefully titrated 
according to the specific, individual needs of the patient. However, whether such 
policy will have impact on clinical outcome is not clear at this moment. A recently 
published review concludes, because of the lack of convincing evidence for 
clinically relevant adverse effects of hyperchloremic acidosis and the limited 
published information on the effects of balanced solutions on outcome, that the 
change of routine practice to balanced colloids cannot be recommended32. 
Nevertheless, balanced colloids are increasingly used in Dutch hospitals.
Part two: metabolic alkalosis in the ICU
In the second part of the thesis, we focused on renal handling of strong ions during 
metabolic alkalosis in critically ill patients. In chapter 5, we examined the mechanism 
of action of the carbonic anhydrase inhibitor acetazolamide in 15 ICU patients 
suffering from metabolic alkalosis. Acetazolamide is clinically used to correct 
metabolic alkalosis, and thereby to facilitate weaning from mechanical ventilation33. 
To this end, we studied the urinary excretion of electrolytes and the resulting change 
in serum pH and Stewart parameters during the 72h after a single intravenous 
administration of acetazolamide. We showed that the maximal and sustained 
correction of serum pH after 24 h was completely explained by a significant 
decrease in serum SIDapp secondary to an increase in serum chloride. Through 
inhibition of carbonic anhydrase in the proximal tubule, reabsorption of chloride 
was facilitated, which was demonstrated by a significant rise in urinary SID after 
administration of acetazolamide. Other independent determinants of serum pH 
where not significantly altered apart from a small decrease in weak acid phosphate 
that has an opposite, alkalizing, effect on serum pH. Acetazolamide-induced loss 
of bicarbonate was not the cause of correction of pH (as it is a dependent 
parameter), but facilitated renal reabsorption of chloride, while sodium could still be 
excreted. The pharmacologic effect of a single dose of acetazolamide seemed to 
exceed its serum half-life (6–8 hours), which was reflected by the 24-hour duration 
of altered urinary sodium and chloride excretion. Furthermore, the correction of 
serum pH was sustained after 24 hours although urinary electrolyte excretion 
returned to pre-administration values. Apparently, the alkalizing factors that were 
originally present in our patients were corrected during the course of the 3 day 
observation period.
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This was the first study in which the Stewart approach was used in ICU patients with 
metabolic alkalosis. Again, these results demonstrate the central role of the kidneys 
in acid base regulation and the utility of the Stewart approach to offer an advanced 
understanding. Although this study increased our insight in the renal handling of 
strong ions during acid base derangements and the influence of pharmacological 
intervention, clinical implications at the bed site may not be apparent. Interestingly 
however, the previously mentioned study of renal tubular acidosis (RTA) patients18 
confirms our results regarding the role of the kidneys in acid base regulation. The 
increase in plasma chloride after intravenous chloride loading in RTA patients, but 
not in controls, was inversely associated with fractional excretion of chloride and 
correlated with blood pH. Similar to our results, the authors concluded that the 
metabolic acidosis was better explained by changes in urinary strong ion difference 
(the Stewart theory) than by changes in urinary bicarbonate excretion.
Part three: apparent normal acid base state in the ICU
In this part of the thesis, we investigated the characteristics of Stewart parameters 
in 312 critically ill patients with normal pH on day 3, 4 or 5 following ICU admission, 
described in chapter 6.  We described the Stewart parameters in 137 patients with 
an apparently normal acid base state according to the traditional criteria (pH, 
PaCO2 and BE within the normal reference range). Furthermore, we explored the 
kinetics of the acid base parameters during the first week of ICU admission to gain 
insight in the way an apparently normal acid base state in critically ill patients 
originates and, subsequently, how it evolves.  
Stewart parameters in three groups with normal pH
Approximately 50% of our studied ICU patients with normal pH had an underlying 
mixed acid base disorder according to conventional criteria (either abnormal BE 
and/or PaCO2). However, even critically ill patients with an apparently normal acid 
base state according to these criteria (pH, PaCO2 and BE all within the reference 
range) had an underlying mixed acid base disorder that became apparent using 
the Stewart approach. Compared with data reported from normal subjects19,34-36, 
this metabolic derangement was characterized by a combination of a low SIDapp 
(due to hyperchloremia), increased SIG (both acidifying effects) and a low level of 
the weak acid albumin (alkalising effect). Apparently, traditional methods of 
assessing acid base status fail to diagnose complicated acid base disorders in 
critically ill patients. Although other authors mentioned previously that acid-base 
differences between healthy volunteers and ICU patients are likely to be present36,37, 
as far as we know our study is the first to report a detailed quantitative analysis of a 
large group of critically ill patients with an apparently normal acid base status. 
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Moreover, our findings suggest that low SIDapp could be viewed as an adaptive 
phenomenon (in response to the high SIG and low albumin levels) during critical 
illness. Hypoalbuminemia (an alkalising factor) is often considered to be an 
inevitable event in critically illness, and albumin doesn’t seem to be a regulated 
variable for acid base purposes. Accordingly, increased SIG levels are probably a 
result of organ dysfuncion and the underlying disease or its therapy (see later). 
However, the low SIDapp values may (at least partially) be an appropriate renal 
response to the alkalising effect of hypoalbuminemia. In this view, our results 
illustrate that in case of hypoalbuminemia SIDapp is reset to a lower level in order to 
maintain pH, as previously suggested36,38. On the other hand, we cannot exclude 
the possibility of hypoalbuminemia being an adaptive response to the high SIG 
levels and/or low SIDapp levels associated with the sequellae of critical illness.
Kinetics of Stewart parameters
We found that levels of SIDapp returned to levels almost completely comparable 
with healthy subjects during the first week of ICU admission, irrespective of whether 
patients had a mixed acid base disorder (according to traditional criteria) or not. 
Additionally, following normalisation of pH, SIG levels remained higher than levels 
reported for healthy subjects and hypoalbuminemia persisted. This is in accordance 
with the recent study of Gunnerson et al, who reported the data of 15 stable ICU 
patients just before ICU discharge. The decrease in SIG levels prior to normalization 
of pH is probably related to (partial) resolution of disease. High (pre-resuscitation) 
SIG levels during admission in ICU are known to be related to the presence of 
sepsis, renal and hepatic dysfunction and are probably a marker of tissue 
hypoperfusion as well8,39-41. Possibly, in our study, when pH is normalized, SIG 
levels are decreased as a result of (partial) recovery of organ function or for example 
institution of renal replacement therapy. The increase of SIDapp levels following 
normalization of pH in our study is almost completely explained by a decrease in 
chloride levels and might be related to further recovery of renal function. For 
example, the ability to excrete excess chloride in urine is related to renal function, 
as previously described in chapter 2c. Furthermore, large amounts of intravenous 
unbalanced fluids are unlikely to be administered in a more stable phase of disease. 
Covariates that modulate acid-base balance
By using multivariate linear regression analysis, we found that low SIDapp levels 
during normal pH were independently related to admission SIDapp levels, low cation 
loading and high chloride loading 24 hours before normal pH. Together, these three 
factors accounted for only 40% of the observed SIDapp levels during normal pH. 
Dilution (electrolyte free volume load) and diuretic use did not reach significance 
following multivariate analysis. Apparently, other factors not accounted for in the 
123
SUMMARY AND GENERAl DISCUSSION
7
analysis also play a role. Potential candidates include infused volume and 
electrolytes in the first two days of admission, anion flux from the intracellular 
compartment and, as mentioned above, presumably increased renal chloride 
retention as an adaptive response to the alkalising factor hypoalbuminemia. SIG 
levels in the patients with normal pH were independently related to creatinine levels, 
the presence of sepsis at admission and SIG levels during admission. Together, 
these three factors accounted for 28% of the observed high SIG levels during 
normal pH. So, again, other factors apparently play an important role, for example 
persistent occult tissue hypoperfusion or hepatic dysfunction. Also, the 
administration of acetaminophen, especially in combination with antibiotics like 
flucloxacillin and/or depleted glutathion reserves can cause high levels of 
pyroglutamic acid42. However, in our study described in chapter 2b as well as a 
previously published study43 on the nature of high SIG levels, pyroglutamic acid 
was not a significant contributing factor. Gelatins, which are comprised of negatively 
charged polypeptides, are a known source of ‘unmeasured’ anions44, but were not 
used in our patients during the conduct of the study. As mentioned previously, the 
nature of the increased SIG in ICU patients in general is currently largely unknown 
and likely multifactorial41. 
In summary, we conclude that the Stewart approach to acid base balance provides 
more insight in the prevalence and nature of metabolic acid base derangements in 
critically ill patients. The more descriptive, traditional Henderson Hasselbalch 
approach (combined with a base excess) offers a fast bedside quantification of the 
metabolic component of an acid-base derangement. However, due to its simplicity 
and assumption of normality of relevant parameters that are often abnormal in the 
critically ill, clinicians not aware of these limitations will falsely diagnose the cause 
of complex metabolic derangements. In contrast, the Stewart approach offers a 
powerful tool to rigorously quantify the relative contribution of all relevant factors 
in a metabolic acid-base disturbance. Furthermore, it results in improved under- 
standing of the role of several contributing factors such as renal dysfunction and 
therapeutic interventions. However, the superiority of the Stewart approach in 
clinical practice might be debated. For example, it is more cumbersome for clinical 
management due its complexity. Also, opponents of the Stewart approach question 
the role of bicarbonate as a dependent variable not influencing pH and criticize the 
emphasis Stewart places on the important role of strong ions45,46. Therefore, the 
traditional approach is still preferred by many. However, if the role of weak acids is 
considered during traditional analysis of a metabolic acid-base disturbance, by 
using the albumin corrected anion gap, advantages of both methods are nicely 
combined. In this way, complex calculations at the bedside can be avoided.
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In spite of our research, several aspects of acid- base derangements in the critically 
ill, using the Stewart approach, still remain unresolved. Therefore, future studies 
may focus on the still largely unidentified part of the SIG, its underlying metabolic 
derangements and its prognostic relevance. Designing a study with a more 
homogeneous study population, for example by selecting only patients with a 
specific disease state such as renal failure may facilitate identification of part of the 
SIG. Furthermore, the clinical significance of hyperchloremic acidosis must be 
further evaluated as well as the effects of different balanced fluids in critical care 
with respect to clinical end points.
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Introductie
Zuur-base stoornissen komen vaak voor bij ernstig zieke Intensive Care (IC-) 
patiënten en hebben, afhankelijk van de oorzaak, invloed op de ernst en de uitkomst 
van de ziekte. Zo heeft bijvoorbeeld een ernstig verlaagde zuurgraad als gevolg 
van een stoornis in de stofwisseling (een metabole acidose) een negatieve invloed 
op verschillende orgaanfuncties en is deze voorspellend voor een slechtere 
uitkomst. De Intensive Care arts  moet dan ook kennis en een goed begrip hebben 
van de normale zuur-base regulatie en het ontstaan van afwijkingen hierin. De 
zuurgraad (pH) van het bloed wordt bepaald door de concentratie H+ ionen. Om 
de oorzaak van een zuur-base  stoornis te achterhalen zijn verschillende analyse-
methoden ontwikkeld sinds het begin van de 20e eeuw. Al deze methoden komen 
overeen wat betreft de beschrijving van de invloed van afwijkingen in de koolzuur-
spanning in het bloed (PCO2) op de pH, die vooral door stoornissen in de 
ademhaling ontstaan. De methoden verschillen echter in de manier waarop zij de 
invloed van afwijkingen in de stofwisseling op de pH vaststellen: de zogenaamde 
metabole component. De oudste methode om de oorzaak van een zuur-base 
stoornis te diagnosticeren (uit 1916) komt voort uit het werk van Henderson en 
Hasselbalch. Deze methode, ook wel de‘traditionele’ methode genoemd,  kan een 
stoornis in de ademhaling als oorzaak van een zuur-base stoornis goed vaststellen. 
Bepaling van de ernst en vooral de aard van complexe metabole stoornissen lukt 
met de traditionele methode echter veel minder goed. De laatste 20 jaar wint een 
kwantitatieve fysisch-chemische benadering van zuur-base stoornissen terrein, 
voor het eerst beschreven in 1980 door Peter Stewart.  De Stewartmethode lijkt 
namelijk beter dan de traditionele methode in staat complexe metabole stoornissen 
te identificeren en kwantificeren. De Stewartmethode is echter wel ingewikkelder en 
bewerkelijker.
De Stewartmethode
Bij de zuur-base analyse volgens Stewart staat het concept centraal dat de pH van 
het bloed alleen kan veranderen door verandering van de mate van uiteenvallen 
(dissociatie) van water in H+ ionen en OH- ionen. Het menselijk lichaam bestaat 
voor een groot gedeelte (50-60%) uit water en is daarom een onuitputtelijke bron 
van H+ ionen. Daarnaast zijn voor de Stewartmethode de wetten van behoud van 
massa en elektroneutraliteit van belang. Verandering in de dissociatie van water (en 
dus verandering van pH) kan, volgens Stewart, alleen plaatsvinden door de invloed 
van drie onafhankelijke factoren:
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1.  het verschil tussen positief en negatief geladen ionen die volledig opgelost zijn, 
zogenaamde  ‘sterke’ ionen. Dit verschil wordt ‘ apparent strong ion difference’ 
of SIDapp genoemd
2.  de hoeveelheid zwakke zuren in het bloed (vooral albumine en fosfaat)
3.  de hoeveelheid koolzuur in het bloed. 
De SIDapp en de hoeveelheid zwakke zuren kunnen veranderen door stoornissen in 
het metabolisme. De SIDapp kan dalen door een relatieve afname van gemeten 
positief geladen deeltjes (kationen) of relatieve toename van gemeten negatief 
geladen deeltjes (anionen). Meestal daalt de SIDapp door een verhoogde 
hoeveelheid lactaat of chloride. Door een daling van de SIDapp en/of een toename 
van de hoeveelheid zwakke zuren dissocieert meer water en zal dus de pH dalen. 
Omgekeerd: als de SIDapp stijgt en/of de hoeveelheid zwakke zuren daalt dissocieert 
minder water en zal dus de pH stijgen. Bij gebruik van de Stewartmethode is er 
daarnaast nog een rol weggelegd voor de zogenaamde ‘strong ion gap’ (SIG). De 
SIG staat voor de hoeveelheid ongemeten negatief geladen deeltjes, stoffen die 
niet standaard in het bloed bepaald (kunnen) worden. Die hoeveelheid negatief 
geladen deeltjes is alleen te bepalen door het verschil in alle gemeten positief en 
negatief geladen deeltjes in het bloed te berekenen. In deze berekening zijn niet 
alleen de sterke ionen opgenomen, zoals in de SIDapp, maar ook de lading van 
bicarbonaat en de zwakke zuren. Als er na deze berekening positieve lading 
overblijft, is er sprake van een verhoogde SIG. Het lichaam kan immers  niet positief 
of negatief geladen zijn (de wet van behoud van elektroneutraliteit). Een verhoogde 
SIG betekent dus een verhoogde hoeveelheid negatief geladen stoffen in het bloed, 
die leidt tot een toename van dissociatie van water (en een daling van de pH). Een 
verhoogde SIG heeft ook een bewezen negatieve invloed op de prognose van de 
IC patiënten, vooral als de verhoogde SIG vastgelegd is voor het begin van de 
therapie.
In dit proefschrift onderzoeken we verschillende aspecten van zuur-base stoornissen 
bij intensive care (IC) patiënten. Hierbij maken we gebruik van de Stewartmethode. 
De nadruk ligt hierbij op metabole stoornissen omdat die gemakkelijk over het 
hoofd gezien kunnen worden bij gebruik van de traditionele methode. Ook heeft de 
aard van de metabole stoornis invloed op de ernst en uitkomst van de ziekte en is 
kennis hierover belangrijk bij het bepalen van de juiste therapie. Dit proefschrift 
bestaat uit drie delen waarin achtereenvolgens aan bod komen: de analyse van 
IC-patienten met een verlaagde zuurgraad (metabole acidose), een verhoogde 
zuurgraad (metabole alkalose) en een normale pH.
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Deel 1.  Oorzaken van metabole acidose op de Intensive Care 
volgens Stewart
De Stewartmethode versus de traditionele methode
Hoofdstuk 2 beschrijft een studie waarin de oorzaken van een metabole acidose bij 
IC-patiënten worden onderzocht. Hierbij vergelijken we de traditionele methode 
met de Stewartmethode wat betreft diagnostische accuraatheid en de toepas-
baarheid in de dagelijkse IC-praktijk. We stellen vast dat metabole acidose bij 
IC-patiënten een complex, multifactorieel ziektebeeld is. Zowel een hoog gehalte 
aan chloride (hyperchloremie) en lactaat (hyperlactatemie) als een verhoogde SIG 
(ongemeten negatief geladen deeltjes, zie boven) komen vaak voor. Bij ongeveer 
de helft van de patiënten zijn deze drie factoren gelijktijdig verantwoordelijk voor de 
acidose. De traditionele methode, gecombineerd met een (ongecorrigeerde) anion 
gap, blijkt te weinig gevoelig te zijn om hyperlactatemie te detecteren. Hyperlac-
tatemie mag in de praktijk niet over het hoofd worden gezien. Het is namelijk 
meestal een uiting van te weinig zuurstofaanbod aan de weefsels (wat consequenties 
heeft voor de behandeling) en is voorspellend voor een slechtere uitkomst. Een 
’anion gap’ gecorrigeerd voor het serum albumine kan hyperlactatemie beter 
detecteren. Bovendien blijkt er een zeer sterk verband te bestaan tussen een voor 
albumine en lactaat gecorrigeerde anion gap en de SIG bij patiënten met een 
metabole acidose op de IC. Zo kan dus de hoeveelheid ongemeten negatief 
geladen deeltjes (verantwoordelijk voor de acidose en van invloed op de uitkomst) 
gemakkelijk bepaald worden zonder dat de complexe berekening van de SIG nodig 
is. We stellen vast dat een SIG concentratie van > 2mEq/l waarschijnlijk abnormaal 
is bij IC patiënten, aangezien een normale (gecorrigeerde) anion gap (<12mEq/l) 
correleert met SIG concentraties van < 2 mEq/l.
De identiteit van de strong ion gap
Ondanks de duidelijke invloed op de prognose van IC-patiënten is de precieze 
aard van de negatief geladen deeltjes die de SIG vormen niet duidelijk. Wel is er 
een duidelijk verband bekend tussen verhoogde SIG en lever- en nierfalen, bloed-
vergiftiging (sepsis) en diverse andere vormen van shock. In hoofdstuk 3 zoeken 
we naar de identiteit van de negatief geladen deeltjes die deel uit maken van de 
strong ion gap (SIG). Dit doen we door 2 groepen IC-patiënten met een metabole 
acidose met elkaar te vergelijken: een groep met een lage (<2mEq/l) SIG en een 
groep met een hoge (≥5 mEq/l) SIG. Door uitgebreide analyse met (onder andere) 
verschillende chromatografie- en massaspectometrie-technieken hebben we 
gezocht naar concentratieverschillen tussen de twee SIG groepen van onder 
andere 25 bekende aminozuren, 9 organische zuren en urinezuur. De meeste van 
deze stoffen zijn namelijk negatief geladen bij een fysiologische pH. Daarnaast 
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kunnen we met deze laboratoriumtechnieken potentieel honderden andere stoffen 
detecteren. Helaas kunnen we slechts 7.9% van het verschil in SIG tussen deze 2 
groepen verklaren door de aanwezigheid van hoge concentraties negatief geladen 
aminozuren, urinezuur en organische zuren. Urinezuur blijkt verantwoordelijk voor 
ongeveer een kwart van de geïdentificeerde SIG. In het chromatogram van de 
aminozuren waren duidelijke pieken aanwezig in de hoge SIG groep, die niet 
aanwezig waren in de lage SIG groep. Nadere identificatie van  deze pieken is nog 
niet verricht. Wel maken we aannemelijk dat ze wat lading betreft niet meer dan 
1.7% aan het verschil in SIG tussen de 2 groepen kunnen bijdragen. We kunnen niet 
bevestigen dat verhoogde concentraties van de intermediairen van de citroenzuur-
cyclus een relevante rol spelen, zoals eerder gesuggereerd in de literatuur. Alle 
concentraties van de citroencyclus intermediairen vallen binnen de referentiewaar-
den. Samenvattend kunnen we over het grootste deel van de bron en identiteit van 
ongemeten anionen die deel uit maken van de SIG nog steeds alleen maar 
speculeren,  ondanks onze inspanningen.
Toekomstige studies zouden zich kunnen richten op specifieke ziektebeelden die 
geassocieerd zijn met een verhoogde SIG. Door een meer homogene groep 
patiënten te selecteren is er wellicht meer kans om de relevante stoffen die bij deze 
patiënten de SIG vormen te identificeren. Bij patiënten met leverfalen zouden 
bijvoorbeeld (metabolieten) van medicijnen zoals antibiotica in verhoogde concentratie 
aanwezig kunnen zijn door verminderde afbraak. Bij patiënten met sepsis zou de 
verhoogde SIG verband kunnen houden met zuurstoftekort op celniveau (weefsel-
schade) of met specifieke ontstekingsproducten. De associatie tussen een verhoogde 
SIG en slechte uitkomst is inmiddels vaak bevestigd. Dit suggereert dat een verhoogde 
SIG onder andere een marker is van weefselschade ten gevolge van shock.
De rol van nierfalen
In hoofdstuk 4 onderzoeken we de rol van nierfalen in het ontstaan van metabole 
acidose. Bij IC patiënten met een metabole acidose hebben we bloed- en 
urinewaarden van relevante stoffen gemeten. Volgens de Stewart approach is de 
enige manier waarop de nieren een acidose zouden kunnen corrigeren, ongeacht 
de oorzaak, de uitscheiding van chloride samen met NH4+ . Omdat dan namelijk 
een sterk anion wordt uitgescheiden zonder een sterk kation stijgt de SIDapp in het 
bloed. In de urine daalt juist de SID door uitscheiding van chloride zonder natrium. 
Bij IC-patiënten met een metabole acidose is een hogere kreatinine waarde 
significant geassocieerd met een hogere SID in de urine. Deze hogere urine SID 
waarden zijn geassocieerd met een lagere pH in het bloed. We concluderen dat 
verminderde uitscheiding van negatieve ionen bij patiënten met nierfalen een factor 
is in het ontstaan van metabole acidose bij deze patiënten. Daarnaast bevestigen 
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we dat acidose bij nierfalen vooral veroorzaakt wordt door een verhoogde SIG en 
een hoge concentratie fosfaat (een zwak zuur). De verhoogde SIG wordt 
waarschijnlijk veroorzaakt door verminderde uitscheiding van ongemeten negatief 
geladen stoffen in de urine. Het belang van renale chlooruitscheiding in de regulatie 
van pH is relevant voor de klinische praktijk. Vooral bij patiënten met een verminderde 
nierfunctie zal ruimhartige toediening met ongebalanceerde vloeistoffen zoals 
bijvoorbeeld ‘fysiologisch zout’ zeer waarschijnlijk een hyperchloremische acidose 
veroorzaken. ‘Fysiologisch zout’ is een tot nu toe veel gebruikte infuusvloeistof die 
relatief veel chloride bevat , waardoor de SIDapp in het bloed daalt na toediening 
van grote hoeveelheden. Aangezien hyperchloremische acidose kan bijdragen aan 
veranderingen in immuunrespons en orgaandysfunctie, is dit mogelijk een klinisch 
relevant fenomeen. Hoewel het effect van hyperchloremische acidose op klinische 
eindpunten als opnameduur en mortaliteit (nog) niet duidelijk is, lijkt het logisch 
om het, wanneer mogelijk, te voorkomen. Tegenwoordig zijn er zogenaamde 
‘gebalanceerde’ infuusvloeistoffen op de markt, waarvan de samenstelling is afgestemd 
op een normale SIDapp in het bloed. Potentieel zal er daarom geen acidose ontstaan 
als deze vloeistof in grote hoeveelheid wordt gegeven aan gezonden. Hoewel een 
effect op klinische uitkomsten van gebalanceerde vloeistoffen in grote groepen 
ernstig zieke patiënten nog niet is aangetoond, worden ze inmiddels in veel 
ziekenhuizen gebruikt. Het verdient waarschijnlijk de voorkeur om niet alleen het 
benodigde volume, maar ook de samenstelling van de infuusvloeistof te titreren op 
de individuele behoefte van de patiënt.
Deel 2.  De Stewartbenadering van metabole alkalose op de 
Intensive Care
In het tweede deel van het proefschrift ligt de nadruk op renale uitscheiding van 
sterke ionen tijdens metabole alkalose. Bij IC-patiënten met een metabole alkalose 
die behandeld worden met een eenmalige intraveneuze dosis acetazolamide, een 
koolzuuranhydraseremmer, bestuderen we het effect op bloed- en urine waarden 
volgens de Stewart methode (in hoofdstuk 5). Acetazolamide wordt op de intensive 
care gebruikt om metabole alkalose te corrigeren en zodoende patiënten 
gemakkelijker te laten ontwennen van de beademing. De belangrijkste bevinding 
van onze  studie is dat de maximale, blijvende correctie van de serum pH na een 
dosis acetazolamide volledig verklaard wordt door een daling van de serum SIDapp 
ten gevolge van een stijging van het serum chloride. De andere onafhankelijke 
determinanten van de pH in het bloed blijken niet te veranderen, met uitzondering 
van een lichte daling van het serum fosfaat die juist een alkaliniserend effect heeft. 
De stijging van het serum chloride na acetazolamide is te verklaren door een 
verhoogde reabsorptie van chloride die zich uit in een significante stijging van de 
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urine SID. Het door acetazolamide geïnduceerde verlies van bicarbonaat in de 
urine is, volgens de Stewart benadering, niet de oorzaak van de pH correctie. 
Bicarbonaat is immers een afhankelijke parameter. Bicarbonaat verlies in de urine 
maakt de reabsorptie van chloride mogelijk terwijl natrium uitgescheiden kan 
worden, waardoor de SIDapp in het bloed daalt. Onze resultaten demonstreren de 
centrale rol van de nieren in de zuur-base regulatie en de bruikbaarheid van de 
Stewartbenadering om hier meer inzicht in te krijgen. 
Deel 3.  Stewartanalyse van IC-patiënten met een ogenschijnlijk 
normaal zuur-base evenwicht 
In hoofdstuk 6 beschrijven we Stewartparameters bij IC-patiënten die, volgens de 
traditionele methode, ogenschijnlijk een normaal zuur-base evenwicht hebben. We 
wilden vaststellen of deze IC-patiënten inderdaad een volledig normaal zuurbase-
evenwicht hebben, of een gecompenseerde of gemengde onderliggende afwijking 
in het zuurbase-evenwicht. Hiertoe onderzoeken we 312 IC-patiënten met een 
normale pH op dag 3,4 of 5 na opname op de intensive care. Ongeveer de helft van 
deze groep heeft een ogenschijnlijk volledig normaal zuur-base evenwicht (normale 
pH, bicarbonaat en koolzuurspanning). Na analyse volgens de Stewartmethode 
blijken deze patiënten, vergeleken met gezonde proefpersonen, een gemengde 
zuur-base stoornis te hebben: een combinatie van lage SIDapp (door hyperchloremie), 
verhoogde SIG en een verlaagd albumine. De eerste twee factoren hebben een 
verzurend effect, hetgeen wordt geneutraliseerd door een verlaagd gehalte van het 
zwakke zuur albumine (hypoalbuminemie). De traditionele methode zal deze 
gecompliceerde zuur-base stoornis niet aan het licht brengen, immers alle gemeten 
parameters van de bloedgas zijn normaal. Onze studie is de eerste gedetailleerde 
kwantitatieve analyse van een grote groep IC-patiënten met een ogenschijnlijk 
normaal zuur-base evenwicht. Hypoalbuminemie wordt meestal als een onvermijdelijk 
fenomeen gezien tijdens ernstige ziekte: een gevolg van lekkage uit de bloedbaan en 
verminderde aanmaak door de lever. Albumine wordt waarschijnlijk niet gereguleerd 
door het lichaam met het doel om het zuur-base evenwicht te handhaven. Analoog 
hieraan is de verhoogde SIG waarschijnlijk onder andere een gevolg van 
verminderde orgaanfunctie en de onderliggende ziekte. De lage SIDapp zou echter 
(in elk geval ten dele) een afspiegeling kunnen zijn van een aanpassing van de nier 
aan het alkaliserende effect van de hypoalbuminemie.
Daarnaast tonen we aan dat de lage SIDapp (tijdens normale pH) onafhankelijk 
geassocieerd is met een lage SIDapp tijdens opname, met een lage hoeveelheid 
kationen en met een hoge hoeveelheid chloride toegediend in het infuus 24 uur 
voorafgaand aan de meting. De hoge SIG (tijdens normale pH) was onafhankelijk 
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geassocieerd met de nierfunctie en met de aanwezigheid van sepsis  en een hoge 
SIG tijdens opname.
Tijdens de eerste week van IC-opname stijgt de SIDapp in het bloed tot waarden die 
vergelijkbaar zijn met die van gezonden. De SIG daalt gedurende de eerste week 
van opname (waarschijnlijk door herstel van orgaanfunctie en bijvoorbeeld het 
starten van nierfunctie vervangende therapie), maar blijft hoger dan de waarden bij 
gezonde proefpersonen. Ook de hypoalbuminemie blijft bestaan.
Samenvattend concluderen we dat de Stewartmethode meer inzicht geeft in het 
voorkomen en de aard van metabole zuur-base stoornissen bij IC-patiënten. Ook 
geeft de Stewartmethode een goede indruk van de rol van de nier bij zuur-base 
stoornissen. De traditionele methode heeft als voordeel dat hij sneller is en een 
redelijke indruk geeft van de ernst van de metabole stoornis. Complexe stoornissen 
kunnen met de traditionele methode echter over het hoofd gezien worden, of niet 
goed worden geïnterpreteerd. Wanneer er bij metabole acidose op de IC de anion 
gap gecorrigeerd wordt voor albumine, worden de voordelen van beide methoden 
gecombineerd. Toekomstige studies zouden zich kunnen richten op nog steeds 
grotendeels onbekende identiteit van de SIG, bijvoorbeeld door een meer geselecteerde 
patiëntengroep te onderzoeken. Daarnaast moet de klinische relevantie van hyper-
chloremische acidose en de effecten van gebalanceerde infuusvloeistoffen op 
klinische eindpunten beter onderzocht worden.
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Dit proefschrift is een kwestie geweest van de lange adem. Velen hebben er een 
bijdrage aan geleverd, al was het maar door geduld en vertrouwen te houden! 
Ondanks het risico dat ik iemand vergeet, wil ik toch graag een aantal mensen 
persoonlijk bedanken.
Prof. dr. Van der Hoeven, beste Hans, jij hebt mij al weer lang geleden in het Groot 
Ziekengasthuis kennis laten maken met klinisch wetenschappelijk onderzoek op de 
IC. Ik vergeet nooit meer hoe je mij, bij mij thuis in Den Bosch met Dirk op schoot, 
in 2007 liet beloven dat mijn boekje af zou komen. Alleen onder die voorwaarde 
mocht ik ‘terug naar Den Bosch’.  Bedankt voor je voortdurende vertrouwen en 
rotsvaste geloof dat die promotie er echt ging komen. Zelf ben ik er niet altijd van 
overtuigd geweest dat ik de eindstreep zou halen, toch is nu die missie eindelijk 
volbracht! Ook wil ik je bedanken dat jij mij hebt ‘binnengehaald’ in de Intensive 
Care. Na de IC-stage in Den Bosch 12 jaar geleden was ik verkocht en heb nog elke 
dag plezier van mijn keuze destijds om intensivist te worden. Als een van de eerste 
fellows van jouw opleiding in Nijmegen, samen met vele bossche collega’s, was het 
een intensieve, maar geweldig leuke en leerzame tijd. Als geen ander weet jij je 
passie en enthousiasme voor het vak over te brengen en mensen te inspireren om 
het beste in zichzelf boven te halen. 
Prof. Dr. Pickkers, beste Peter, jij bent een briljante wetenschapper, vol originele 
ideeën en met een groot vermogen anderen te motiveren en mee te laten delen in 
je successen en goede ingevingen. Niet voor niets al zo jong professor, met een 
grote club goede, gedreven en veelbelovende jonge wetenschappers om je heen, 
die terecht allemaal graag blijven. Ook uniek door je ‘specifieke’ humor. Ik heb grote 
bewondering voor jouw optimisme en tomeloze energie. Altijd zie je wel een oplossing 
voor problemen met data, formuleringen en ander (voor jou niet bestaand) 
wetenschapsleed. Zonder jou was dit proefschrift er waarschijnlijk niet geweest. 
Dank voor je enthousiaste begeleiding en steeds zeer waardevolle inbreng.
Dr. Van der Voort, beste Peter, hartelijk dank voor je hulp als co-promotor en 
belangstelling ‘op afstand’ vanuit Amsterdam. Ik ben blij dat, na alle inspanningen, 
ook de data uit het OlVG de basis vormen voor een mooi hoofdstuk in dit proefschrift.
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